{
  "meta": {
    "title": "Late_Night_Pyq_Pyt_Medicine-10",
    "url": "https://brainandscalpel.vercel.app/late-night-pyq-pyt-medicine-10-30cd49e2.html",
    "scrapedAt": "2025-11-29T18:10:05.192Z"
  },
  "questions": [
    {
      "id": 54298,
      "choices": [
        {
          "id": 216661,
          "text": "<p><span style=\"font-size:12.0pt;\">NREM1</span></p>"
        },
        {
          "id": 216662,
          "text": "<p><span style=\"font-size:12.0pt;\">NREM2</span></p>"
        },
        {
          "id": 216663,
          "text": "<p><span style=\"font-size:12.0pt;\">NREM3</span></p>"
        },
        {
          "id": 216664,
          "text": "<p><span style=\"font-size:12.0pt;\">REM</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;Identify the stage of sleep based on the EEG shown below:</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-131403.jpg\" alt=\"\" width=\"500\" height=\"246\"></span></p>",
      "unique_key": "Q7209268",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446534,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>D) REM</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The EEG provided shows a pattern that mimics an awake state, which is indicative of REM (Rapid Eye Movement) sleep. REM sleep is characterized by specific EEG, EOG (electro-oculogram), and EMG (electromyogram) patterns:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>EEG (Electroencephalogram):</strong> During REM sleep, the EEG shows low amplitude, mixed frequency activity that resembles the awake state. This is in contrast to the high amplitude, low-frequency waves seen in NREM (Non-Rapid Eye Movement) sleep stages.</span></li><li><span style=\"font-size:12.0pt;\"><strong>EOG (Electro-oculogram):</strong> The EOG shows rapid eye movements, which are characteristic of REM sleep. These movements are visible as sharp spikes or fluctuations in the EOG tracing.</span></li><li><span style=\"font-size:12.0pt;\"><strong>EMG (Electromyogram):</strong> The EMG shows muscle atonia or paralysis, which is another hallmark of REM sleep. This paralysis prevents the sleeper from acting out their dreams. Only the diaphragm and extraocular muscles remain active during REM sleep.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. NREM1:</strong> This is the lightest stage of sleep, characterized by a transition from wakefulness to sleep. The EEG shows a mix of alpha and theta waves, with some slow eye movements, but it does not resemble the awake state as closely as REM sleep does.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. NREM2:</strong> This stage is marked by sleep spindles and K-complexes on the EEG. It is a deeper stage of sleep than NREM1 but does not show the rapid eye movements or muscle atonia seen in REM sleep.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. NREM3:</strong> Also known as slow-wave sleep (SWS), this stage is characterized by high amplitude, low-frequency delta waves on the EEG. It is the deepest stage of NREM sleep and does not resemble the awake state.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">REM sleep is characterized by EEG patterns similar to wakefulness, rapid eye movements on EOG, and muscle atonia on EMG.</span></p>",
      "correct_choice_id": 216664,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54298/INI-CET_May_2024Medicine_Question_43.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54298/INI-CET_May_2024Medicine_Question_43.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54299,
      "choices": [
        {
          "id": 216665,
          "text": "<p><span style=\"font-size:12.0pt;\">Age &gt; 50</span></p>"
        },
        {
          "id": 216666,
          "text": "<p><span style=\"font-size:12.0pt;\">Temporal tenderness</span></p>"
        },
        {
          "id": 216667,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic Cocaine use</span></p>"
        },
        {
          "id": 216668,
          "text": "<p><span style=\"font-size:12.0pt;\">Subacute progression over 4 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is NOT indicative of underlying serious pathology in headache?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3948735",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446535,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Chronic Cocaine use</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While acute cocaine use can lead to serious complications such as intracranial hemorrhage, chronic cocaine use does not typically present as a headache warning sign for serious pathology unless associated with acute episodes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Age &gt; 50</strong>: New onset headache in individuals over 50 years of age is a red flag and suggests the possibility of serious conditions such as giant cell arteritis or intracranial mass lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Temporal tenderness</strong>: This is often a sign of temporal arteritis (giant cell arteritis), a serious condition that can lead to blindness if not treated promptly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Subacute progression over 4 weeks</strong>: This indicates a progressive condition such as a brain tumor or increased intracranial pressure, which are serious pathologies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic cocaine use is not typically indicative of a serious underlying pathology in headache unless associated with acute episodes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Headache Symptoms That Suggest a Serious Underlying Disorder</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Sudden-onset headache</span></li><li><span style=\"font-size:12.0pt;\">First severe headache</span></li><li><span style=\"font-size:12.0pt;\">\"Worst\" headache ever</span></li><li><span style=\"font-size:12.0pt;\">Vomiting that precedes headache</span></li><li><span style=\"font-size:12.0pt;\">Subacute worsening over days or weeks</span></li><li><span style=\"font-size:12.0pt;\">Pain induced by bending, lifting, coughing</span></li><li><span style=\"font-size:12.0pt;\">Pain that disturbs sleep or presents immediately upon awakening</span></li><li><span style=\"font-size:12.0pt;\">Known systemic illness</span></li><li><span style=\"font-size:12.0pt;\">Onset after age 55</span></li><li><span style=\"font-size:12.0pt;\">Fever or unexplained systemic signs</span></li><li><span style=\"font-size:12.0pt;\">Abnormal neurologic examination</span></li><li><span style=\"font-size:12.0pt;\">Pain associated with local tenderness, e.g., region of temporal artery</span></li></ul>",
      "correct_choice_id": 216667,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54299/INI-CET_May_2024Medicine_Question_44.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54299/INI-CET_May_2024Medicine_Question_44.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54300,
      "choices": [
        {
          "id": 216669,
          "text": "<p><span style=\"font-size:12.0pt;\">Coiling</span></p>"
        },
        {
          "id": 216670,
          "text": "<p><span style=\"font-size:12.0pt;\">Embolization</span></p>"
        },
        {
          "id": 216671,
          "text": "<p><span style=\"font-size:12.0pt;\">Basal stent placement</span></p>"
        },
        {
          "id": 216672,
          "text": "<p><span style=\"font-size:12.0pt;\">Balloon Angioplasty</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Interventional technique used for the management of cerebral aneurysm:</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q1145412",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446536,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Coiling</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The management of cerebral aneurysms, particularly berry aneurysms, involves two primary interventional techniques: clipping and coiling.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Coiling</strong>: This is an endovascular procedure where a catheter is inserted through the femoral artery and navigated to the aneurysm. Coils are then deployed into the aneurysm to induce thrombosis and prevent rupture. Coiling has lower morbidity and mortality rates compared to surgical clipping and is preferred if the aneurysm is accessible for endovascular treatment.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clipping</strong>: This involves a craniotomy where the skull is opened, and a clip is placed at the neck of the aneurysm to isolate it from the circulation. While effective, it is more invasive compared to coiling.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.</strong> <strong>Embolization</strong>: While embolization is used in various vascular interventions, it is not the preferred technique for managing cerebral aneurysms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Basal stent placement</strong>: Stents may be used as an adjunct to coiling to support the coil mass and ensure complete occlusion of the aneurysm, but stent placement alone is not effective for managing aneurysms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Balloon Angioplasty</strong>: This technique is used to dilate narrowed blood vessels but is not suitable for treating aneurysms as it can worsen the aneurysm by increasing the risk of rupture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The preferred interventional technique for the management of cerebral aneurysms is endovascular coiling due to its lower morbidity and mortality compared to surgical clipping.</span></p>",
      "correct_choice_id": 216669,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54300/INI-CET_May_2024Medicine_Question_45.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "INICET",
        "InstrumentsBased",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54300/INI-CET_May_2024Medicine_Question_45.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54301,
      "choices": [
        {
          "id": 216673,
          "text": "<p><span style=\"font-size:12.0pt;\">Acyclovir</span></p>"
        },
        {
          "id": 216674,
          "text": "<p><span style=\"font-size:12.0pt;\">Corticosteroids</span></p>"
        },
        {
          "id": 216675,
          "text": "<p><span style=\"font-size:12.0pt;\">Antibiotics</span></p>"
        },
        {
          "id": 216676,
          "text": "<p><span style=\"font-size:12.0pt;\">Physiotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old patient presented with left facial weakness. Routine lab workup was normal. What is the next best step in management?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q6451864",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446537,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Corticosteroids</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presentation of left facial weakness with normal routine lab workup suggests Bell's palsy, an idiopathic condition characterized by sudden onset of unilateral lower motor neuron facial paralysis. Bell's palsy is a diagnosis of exclusion and is the most common cause of unilateral facial paralysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Corticosteroids:</strong> The first-line treatment for Bell's palsy is corticosteroids. They are most effective when started within 72 hours of symptom onset. Early treatment with corticosteroids can significantly improve the chances of complete recovery. A typical regimen is prednisolone or prednisone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Dosage:</strong> Prednisone 60-80 mg per day for 5-7 days, followed by a taper over the next 5-7 days.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Note – In the severity grading system, <strong>House-Brackmann grading</strong>, if the patient has <strong>Grade 4 or Grade 5</strong> severity, consider adding <strong>antivirals</strong> such as <strong>acyclovir</strong> or <strong>valacyclovir</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acyclovir:</strong> Although acyclovir or other antiviral agents like valacyclovir are sometimes used, their benefit is less clear. They may be considered in severe cases of Bell's palsy, particularly when there is a suspicion of herpes simplex virus involvement, but they are not the primary treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Dosage:</strong> Valacyclovir 1 gram TID for 7 days or acyclovir 400 mg five times a day for 7-10 days.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note - Valacyclovir</strong> has superior bioavailability, superior efficacy, and lower side effects compared to <strong>acyclovir.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Antibiotics:</strong> There is no role for antibiotics in the treatment of Bell's palsy as it is not caused by a bacterial infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Physiotherapy:</strong> While physiotherapy, including facial exercises and eye protection measures, can be supportive, it is not the primary treatment and should be considered an adjunct to corticosteroid therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The best initial management for a patient with Bell's palsy is corticosteroid therapy. Early administration within 72 hours of symptom onset greatly enhances the likelihood of complete recovery. Antivirals may be added in severe cases, but they are not the mainstay of treatment.</span></p>",
      "correct_choice_id": 216674,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54301/INI-CET_May_2024Medicine_Question_46.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54301/INI-CET_May_2024Medicine_Question_46.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54302,
      "choices": [
        {
          "id": 216677,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 216678,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 216679,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 216680,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following clinical features can be encountered in Korsakoff psychosis?</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Amnesia</span></li><li><span style=\"font-size:12.0pt;\">Confabulation</span></li><li><span style=\"font-size:12.0pt;\">Ophthalmoplegia</span></li><li><span style=\"font-size:12.0pt;\">Peripheral neuropathy</span></li></ol>",
      "unique_key": "Q2519285",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446538,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 1, 2, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Korsakoff psychosis, or Korsakoff syndrome, is a chronic neuropsychiatric syndrome resulting from chronic deficiency of thiamine (vitamin B1), commonly associated with chronic alcoholism. It is often considered an irreversible condition, unlike its acute counterpart, Wernicke's encephalopathy, which can be treated with thiamine supplementation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical Features of Korsakoff Psychosis:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Amnesia:</strong> Korsakoff syndrome is characterized by severe memory impairment, both anterograde (inability to form new memories) and retrograde (loss of previously formed memories) amnesia. Long-term memory, however, tends to remain relatively intact.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Confabulation:</strong> Patients often exhibit confabulation, where they fabricate stories to fill gaps in their memory. This is not intentional lying but a way to compensate for memory loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Peripheral Neuropathy:</strong> Chronic alcoholics often suffer from peripheral neuropathy due to thiamine deficiency and direct neurotoxic effects of alcohol. This neuropathy involves the axons of peripheral nerves and manifests as numbness, tingling, and pain in the extremities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Not a Feature of Korsakoff Psychosis:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Ophthalmoplegia:</strong> This is a feature of Wernicke's encephalopathy, which presents acutely with a triad of ophthalmoplegia, ataxia, and confusion. Ophthalmoplegia refers to paralysis or weakness of the eye muscles. It is reversible with thiamine treatment and is not typically seen in the chronic phase of Korsakoff syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Korsakoff psychosis is characterized by severe memory impairment (amnesia), confabulation, and peripheral neuropathy. It does not include ophthalmoplegia, which is a feature of the acute Wernicke's encephalopathy.</span></p>",
      "correct_choice_id": 216677,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54302/INI-CET_May_2024Medicine_Question_47.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54302/INI-CET_May_2024Medicine_Question_47.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54303,
      "choices": [
        {
          "id": 216681,
          "text": "<p><span style=\"font-size:12.0pt;\">Adduction</span></p>"
        },
        {
          "id": 216682,
          "text": "<p><span style=\"font-size:12.0pt;\">Abduction</span></p>"
        },
        {
          "id": 216683,
          "text": "<p><span style=\"font-size:12.0pt;\">Depression</span></p>"
        },
        {
          "id": 216684,
          "text": "<p><span style=\"font-size:12.0pt;\">Intorsion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;All of the following are functions of the superior oblique except:</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8278160",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446539,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Adduction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Adduction</strong> is not a function of the superior oblique muscle. Adduction involves moving the eyeball towards the midline (towards the nose), and this movement is primarily mediated by the medial rectus muscle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Abduction:</strong> The superior oblique muscle helps in the lateral movement of the eyeball, meaning it moves the eye away from the midline (abduction).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Depression:</strong> When the eye is adducted (turned towards the nose), the superior oblique muscle helps to depress the eyeball, moving it downward.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Intorsion:</strong> This is the primary function of the superior oblique muscle. Intorsion involves the rotation of the top of the eyeball towards the nose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The superior oblique muscle is one of the extraocular muscles and is innervated by the trochlear nerve (cranial nerve IV). The primary functions of the superior oblique muscle can be remembered using the mnemonic \"SO-LID\":</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>S</strong>uperior <strong>O</strong>blique</span></li><li><span style=\"font-size:12.0pt;\"><strong>L</strong>ateral movement (Abduction)</span></li><li><span style=\"font-size:12.0pt;\"><strong>I</strong>ntorsion</span></li><li><span style=\"font-size:12.0pt;\"><strong>D</strong>epression</span></li></ul>",
      "correct_choice_id": 216681,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54303/INI-CET_May_2024Medicine_Question_48.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54303/INI-CET_May_2024Medicine_Question_48.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59422,
      "choices": [
        {
          "id": 237001,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumatocele</span></p>"
        },
        {
          "id": 237002,
          "text": "<p><span style=\"font-size:12.0pt;\">Empyema</span></p>"
        },
        {
          "id": 237003,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumothorax</span></p>"
        },
        {
          "id": 237004,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung abscess</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male presented with fever of 102°F with foul-smelling sputum for 5 days. On examination, clubbing was noted in the digits. Chest X-ray is shown below. What is the most likely diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-25-125708.jpg\" alt=\"\" width=\"300\" height=\"276\"></span></p>",
      "unique_key": "Q7372329",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446540,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>D) Lung abscess</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation, including fever, foul-smelling sputum, and digital clubbing, suggests a chronic lung infection. The chest X-ray shows a thick-walled cavity with an air-fluid level, which is a characteristic feature of a lung abscess. A lung abscess is a localized area of pus formation within the lung parenchyma, often resulting from aspiration pneumonia or a necrotizing infection. The presence of an air-fluid level within a thick-walled cavity is the hallmark radiographic sign of a lung abscess.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Thick-walled cavity:</strong> The presence of thick walls around the cavity distinguishes it from other causes of cavitary lung lesions.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Air-fluid level:</strong> This feature indicates the presence of a fluid collection within the cavity, which is typical of an abscess.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pneumatocele:</strong> Pneumatoceles are thin-walled air-filled cysts usually resulting from trauma or certain infections like Staphylococcus aureus pneumonia. They do not present with thick walls or air-fluid levels as seen in a lung abscess.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Empyema:</strong> Empyema is a collection of pus within the pleural space, typically seen on the periphery of the lung rather than centrally. It presents as a pleural-based opacity, often with a split pleura sign on imaging, which is absent in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pneumothorax:</strong> Pneumothorax is the presence of air in the pleural space, leading to lung collapse. It does not present with a thick-walled cavity or air-fluid levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A thick-walled cavity with an air-fluid level on imaging, especially in the context of fever and foul-smelling sputum, is indicative of a lung abscess.</span></p>",
      "correct_choice_id": 237004,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59422/Neet_Pg_Aug_2024_Medicine_Q_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59422/Neet_Pg_Aug_2024_Medicine_Q_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59423,
      "choices": [
        {
          "id": 237005,
          "text": "<p><span style=\"font-size:12.0pt;\">Tuberculosis</span></p>"
        },
        {
          "id": 237006,
          "text": "<p><span style=\"font-size:12.0pt;\">Heart failure</span></p>"
        },
        {
          "id": 237007,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic failure</span></p>"
        },
        {
          "id": 237008,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal failure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old patient presented with shortness of breath, and further evaluation revealed a right pleural effusion. Upon analysis, pleural fluid showed LDH that is 0.7 times the serum LDH and protein that is 0.6 times the serum protein. What is the most likely diagnosis? (NEET PG 2024)</span></p>",
      "unique_key": "Q4050615",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446541,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tuberculosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The pleural fluid values provided are consistent with an exudative effusion based on Light’s criteria:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Light’s Criteria for Exudative Effusion (any one of the following):</span></li><li><span style=\"font-size:12.0pt;\">Pleural fluid protein / serum protein ratio &gt; 0.5</span></li><li><span style=\"font-size:12.0pt;\">Pleural fluid LDH / serum LDH ratio &gt; 0.6</span></li><li><span style=\"font-size:12.0pt;\">Pleural fluid LDH &gt; 2/3 the upper limit of normal serum LDH</span></li><li><span style=\"font-size:12.0pt;\">This case satisfies both the first and second criteria:</span></li><li><span style=\"font-size:12.0pt;\">Protein ratio = 0.6 &gt; 0.5</span></li><li><span style=\"font-size:12.0pt;\">LDH ratio = 0.7 &gt; 0.6</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, it is an exudative effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tuberculosis is a common cause of exudative pleural effusion, especially in endemic areas like India. The effusion is typically lymphocyte predominant and due to pleural inflammation and increased capillary permeability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Heart failure:</strong> Commonly causes transudative effusion due to increased hydrostatic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hepatic failure:</strong> Usually results in transudative effusion, especially in cirrhosis (hepatic hydrothorax), due to low oncotic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Renal failure:</strong> Leads to transudative effusion due to fluid overload or low albumin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tuberculosis causes exudative pleural effusions due to pleural inflammation. In contrast, heart failure, hepatic failure, and renal failure typically cause transudative effusions.</span></p>",
      "correct_choice_id": 237005,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59423/Neet_Pg_Aug_2024_Medicine_Q_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59423/Neet_Pg_Aug_2024_Medicine_Q_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59424,
      "choices": [
        {
          "id": 237009,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased PCWP</span></p>"
        },
        {
          "id": 237010,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary thromboembolism</span></p>"
        },
        {
          "id": 237011,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-cardiogenic pulmonary edema</span></p>"
        },
        {
          "id": 237012,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspiration pneumonitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old man presented with acute epigastric pain and nausea. Lab reports showed an increase in serum lipase levels. He received 2L of fluids during admission, and three days after stabilization, he developed sudden breathlessness. Chest X-ray is shown. What is the likely diagnosis?(NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-25-125752.jpg\" alt=\"\" width=\"300\" height=\"216\"></span></p>",
      "unique_key": "Q1468953",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446542,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Non-cardiogenic pulmonary edema</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient’s presentation with acute epigastric pain, nausea, and elevated lipase levels suggests acute pancreatitis. The development of sudden breathlessness and the presence of bilateral infiltrates on chest X-ray, in the setting of pancreatitis, is highly indicative of Acute Respiratory Distress Syndrome (ARDS), a form of non-cardiogenic pulmonary edema. ARDS is a severe complication associated with acute pancreatitis and is characterized by bilateral infiltrates on imaging, often symmetric, without evidence of heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Increased PCWP:</strong> An increased Pulmonary Capillary Wedge Pressure (PCWP) suggests cardiogenic pulmonary edema, typically seen in heart failure, not ARDS. In ARDS, PCWP is normal or low, as the edema is non-cardiogenic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pulmonary thromboembolism:</strong> Pulmonary thromboembolism usually presents with sudden onset dyspnea, chest pain, and possibly hemoptysis, but it does not typically cause bilateral infiltrates on chest X-ray as seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aspiration pneumonitis:</strong> Aspiration pneumonitis commonly causes unilateral infiltrates initially, especially in the right lower lobe, due to the anatomical position of the bronchus. While aspiration can progress to ARDS, the history provided does not suggest aspiration, making it an unlikely primary diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ARDS is a potential severe complication of acute pancreatitis, presenting with non-cardiogenic pulmonary edema characterized by bilateral infiltrates and normal PCWP</span></p>",
      "correct_choice_id": 237011,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59424/Neet_Pg_Aug_2024_Medicine_Q_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59424/Neet_Pg_Aug_2024_Medicine_Q_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59425,
      "choices": [
        {
          "id": 237013,
          "text": "<p><span style=\"font-size:12.0pt;\">Foville syndrome</span></p>"
        },
        {
          "id": 237014,
          "text": "<p><span style=\"font-size:12.0pt;\">Locked In syndrome</span></p>"
        },
        {
          "id": 237015,
          "text": "<p><span style=\"font-size:12.0pt;\">Millard-Gubler syndrome</span></p>"
        },
        {
          "id": 237016,
          "text": "<p><span style=\"font-size:12.0pt;\">Wallenberg syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old patient presents with left-sided arm and leg weakness, right-sided facial paralysis, and horizontal gaze palsy. Based on the clinical presentation, which of the following is most consistent with the diagnosis? (NEET PG 2024)</span></p>",
      "unique_key": "Q8242471",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446543,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Foville syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Foville syndrome is a brainstem stroke syndrome characterized by contralateral hemiparesis (weakness on the opposite side of the body) and ipsilateral cranial nerve palsies, specifically involving cranial nerves VI (abducens nerve) and VII (facial nerve), as well as horizontal gaze palsy due to involvement of the paramedian pontine reticular formation (PPRF) or medial longitudinal fasciculus (MLF). The combination of left-sided hemiparesis, right-sided facial paralysis, and horizontal gaze palsy is classical for Foville syndrome, making it the correct diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Locked In syndrome:</strong> This syndrome results from a lesion in the ventral pons, leading to quadriparesis (paralysis of all four limbs) and loss of voluntary movement except for vertical eye movements and blinking. It does not match the presentation of unilateral weakness with specific cranial nerve involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Millard-Gubler syndrome:</strong> This syndrome involves contralateral hemiparesis with ipsilateral cranial nerve VI (abducens nerve) and VII (facial nerve) palsy but does not present with horizontal gaze palsy, which is the key differentiating feature from Foville syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Wallenberg syndrome:</strong> Also known as lateral medullary syndrome, Wallenberg syndrome primarily involves sensory deficits, including pain and temperature loss on one side of the face and the opposite side of the body. It does not typically involve significant motor weakness or cranial nerve VI or VII palsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Foville syndrome involves contralateral hemiparesis, ipsilateral cranial nerve palsies, and horizontal gaze palsy due to brainstem involvement, distinguishing it from other stroke syndromes.</span></p>",
      "correct_choice_id": 237013,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59425/Neet_Pg_Aug_2024_Medicine_Q_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59425/Neet_Pg_Aug_2024_Medicine_Q_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59426,
      "choices": [
        {
          "id": 237017,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic SDH</span></p>"
        },
        {
          "id": 237018,
          "text": "<p><span style=\"font-size:12.0pt;\">Intraparenchymal hemorrhage</span></p>"
        },
        {
          "id": 237019,
          "text": "<p><span style=\"font-size:12.0pt;\">Subarachnoid hemorrhage</span></p>"
        },
        {
          "id": 237020,
          "text": "<p><span style=\"font-size:12.0pt;\">Epidural hemorrhage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old man with a history of recurrent falls presented with headache and confusion. CT scan of the patient is shown. Which of the following is correct? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-25-125809.jpg\" alt=\"\" width=\"300\" height=\"276\"></span></p>",
      "unique_key": "Q8022378",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446544,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Chronic SDH (Subdural Hemorrhage)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The CT scan of the patient shows a crescent-shaped hypodensity on the lateral side of the brain, indicative of a subdural hemorrhage (SDH). In the context of this patient, the hypodensity suggests that the bleeding is chronic. Chronic SDH typically appears darker (hypodense) on CT imaging due to the breakdown of blood products over time.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic SDH is common in elderly patients, especially those with a history of recurrent falls or those taking antiplatelet or anticoagulant medications. This condition can occur after even trivial trauma, which elderly patients may not recall. The bleeding occurs between the dura mater and the arachnoid membrane, leading to the characteristic crescent shape seen on imaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Intraparenchymal hemorrhage:</strong> This type of hemorrhage occurs within the brain tissue itself and typically appears as a hyperdense (bright) area on CT in the acute phase. It does not present with the crescent shape seen in subdural hemorrhages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Subarachnoid hemorrhage:</strong> This hemorrhage occurs in the space between the brain and the arachnoid membrane, often appearing as bright, hyperdense areas in the sulci and basal cisterns on CT. It does not have the characteristic crescent shape of a subdural hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Epidural hemorrhage:</strong> Epidural hemorrhages usually present as a biconvex (lens-shaped) hyperdensity on CT, typically associated with trauma, especially to the middle meningeal artery. It is not consistent with the crescent-shaped hypodensity seen in this patient’s scan.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic subdural hemorrhage presents as a crescent-shaped hypodense area on CT and is common in elderly patients with a history of falls or those on anticoagulant therapy.</span></p>",
      "correct_choice_id": 237017,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59426/Neet_Pg_Aug_2024_Medicine_Q_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59426/Neet_Pg_Aug_2024_Medicine_Q_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59427,
      "choices": [
        {
          "id": 237021,
          "text": "<p><span style=\"font-size:12.0pt;\">Neurofibromatosis</span></p>"
        },
        {
          "id": 237022,
          "text": "<p><span style=\"font-size:12.0pt;\">Li-Fraumeni syndrome</span></p>"
        },
        {
          "id": 237023,
          "text": "<p><span style=\"font-size:12.0pt;\">Von Hippel-Lindau syndrome</span></p>"
        },
        {
          "id": 237024,
          "text": "<p><span style=\"font-size:12.0pt;\">Tuberous sclerosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with headaches, confusion, and has recently been diagnosed with a brain tumor. MRI of the brain revealed a cerebellar mass. The family history reveals occurrences of both brain and kidney tumors. Which of the following conditions is most likely associated with this clinical presentation? (NEET PG 2024)</span></p>",
      "unique_key": "Q6260875",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446545,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Von Hippel-Lindau syndrome</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Von Hippel-Lindau (VHL) syndrome is an inherited disorder characterized by the development of multiple tumors and cysts in different parts of the body. This syndrome is strongly associated with cerebellar hemangioblastomas (a type of brain tumor) and renal cell carcinoma (RCC), among other types of tumors. The clinical presentation of a cerebellar mass along with a family history of both brain and kidney tumors is highly suggestive of VHL syndrome. The presence of these tumors in a familial pattern fits the diagnostic criteria for VHL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Neurofibromatosis:</strong> This genetic condition often presents with nerve sheath tumors (neurofibromas), optic gliomas, and café-au-lait spots but does not typically involve both cerebellar tumors and kidney tumors such as RCC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Li-Fraumeni syndrome:</strong> Li-Fraumeni is associated with a variety of cancers, including brain tumors, sarcomas, and breast cancer, due to TP53 mutations. However, it does not specifically link cerebellar and kidney tumors as seen in VHL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tuberous sclerosis:</strong> This condition is characterized by benign tumors in multiple organs, including the brain (subependymal giant cell astrocytomas) and kidneys (angiomyolipomas). However, it does not fit the combination of cerebellar tumors and RCC typical of VHL syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Von Hippel-Lindau syndrome is associated with cerebellar hemangioblastomas and renal cell carcinoma, especially in the context of familial occurrences. Recognizing the combination of brain and kidney tumors should prompt consideration of VHL.</span></p>",
      "correct_choice_id": 237023,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59427/Neet_Pg_Aug_2024_Medicine_Q_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59427/Neet_Pg_Aug_2024_Medicine_Q_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59428,
      "choices": [
        {
          "id": 237025,
          "text": "<p><span style=\"font-size:12.0pt;\">CBNAAT of CSF</span></p>"
        },
        {
          "id": 237026,
          "text": "<p><span style=\"font-size:12.0pt;\">PET scan</span></p>"
        },
        {
          "id": 237027,
          "text": "<p><span style=\"font-size:12.0pt;\">NMR spectroscopy</span></p>"
        },
        {
          "id": 237028,
          "text": "<p><span style=\"font-size:12.0pt;\">B scan of both the eyes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old patient presented with GTCS (Generalized Tonic-Clonic Seizures) and was admitted. CECT is shown below. Which of the following can be useful in establishing the diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-25-125825.jpg\" alt=\"\" width=\"300\" height=\"297\"></span></p>",
      "unique_key": "Q9725002",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446546,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) NMR spectroscopy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The CECT scan shows a single ring-enhancing lesion near the parieto-occipital region, which raises differential diagnoses, including brain abscess, primary CNS lymphoma, tuberculoma, and neurocysticercosis. Among these, the most relevant differential in this patient is tuberculoma versus neurocysticercosis. NMR (Nuclear Magnetic Resonance) spectroscopy is useful in distinguishing between these conditions. In tuberculoma, NMR spectroscopy typically shows a characteristic lipid and/or lactate peak, while in neurocysticercosis, it shows multiple amino acid peaks. This makes NMR spectroscopy the most appropriate tool for establishing the diagnosis in this clinical context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. CBNAAT of CSF:</strong> CBNAAT (Cartridge Based Nucleic Acid Amplification Test) of CSF is primarily used to confirm TB meningitis, which is not the primary suspicion in this patient. The clinical presentation does not fit TB meningitis, and the test is unlikely to be positive in cases of tuberculoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. PET scan:</strong> A PET scan is typically useful for assessing metabolic activity in tumors but is not the best initial choice for differentiating tuberculoma from neurocysticercosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. B scan of both the eyes:</strong> A B scan, or ultrasound of the eyes, is used if intraocular neurocysticercosis is suspected. However, there is no indication of ocular involvement in this patient, making it less relevant for this particular diagnostic dilemma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NMR spectroscopy is valuable in distinguishing between tuberculoma and neurocysticercosis, especially when a single ring-enhancing lesion is present on imaging.</span></p>",
      "correct_choice_id": 237027,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59428/Neet_Pg_Aug_2024_Medicine_Q_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59428/Neet_Pg_Aug_2024_Medicine_Q_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59429,
      "choices": [
        {
          "id": 237029,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum ceruloplasmin</span></p>"
        },
        {
          "id": 237030,
          "text": "<p><span style=\"font-size:12.0pt;\">Urinary copper excretion</span></p>"
        },
        {
          "id": 237031,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic copper content</span></p>"
        },
        {
          "id": 237032,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum copper</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old patient with a history of Wilson’s disease presents with neurological manifestations. Which of the following is the best diagnostic modality? (NEET PG 2024)</span></p>",
      "unique_key": "Q8698219",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446547,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Hepatic copper content</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Wilson’s disease is a genetic disorder that leads to excessive accumulation of copper in the liver, brain, and other tissues, causing hepatic, neurological, and psychiatric symptoms. The gold standard diagnostic test for Wilson’s disease, particularly when definitive diagnosis is required, is measuring hepatic copper content through a liver biopsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A hepatic copper content greater than 250 micrograms per gram of dry liver weight confirms the diagnosis of Wilson’s disease. Although other conditions, such as chronic cholestatic diseases, can also lead to increased hepatic copper, this remains the most specific and sensitive diagnostic test for Wilson’s disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Serum ceruloplasmin:</strong> This is a screening test used in diagnosing Wilson’s disease. In Wilson’s disease, ceruloplasmin levels are typically reduced. However, it is not specific and can be affected by other conditions, making it unsuitable as a definitive diagnostic test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Urinary copper excretion:</strong> Urinary copper excretion is often elevated in Wilson’s disease (greater than 100 micrograms in 24 hours). This test is supportive but not definitive, as increased copper excretion can also occur in other liver conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Serum copper:</strong> Measuring serum copper is generally not useful in the diagnosis of Wilson’s disease. Total serum copper is often low because most serum copper is bound to ceruloplasmin, which is reduced in Wilson's disease. Free copper (non-ceruloplasmin-bound) may be elevated, but this measure lacks specificity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The gold standard for diagnosing Wilson’s disease is the assessment of hepatic copper content through liver biopsy, which is essential for definitive diagnosis</span></p>",
      "correct_choice_id": 237031,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59429/Neet_Pg_Aug_2024_Medicine_Q_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59429/Neet_Pg_Aug_2024_Medicine_Q_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59430,
      "choices": [
        {
          "id": 237033,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 4 RTA</span></p>"
        },
        {
          "id": 237034,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 1 RTA</span></p>"
        },
        {
          "id": 237035,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 2 RTA</span></p>"
        },
        {
          "id": 237036,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following conditions is most likely based on the lab values shown - Blood pH 7.28, Na 138 mEq/L, K 2.8 mEq/L, Cl 113 mEq/L, HCO3 12 mEq/L, BUN 3 mg/dL, and creatinine 0.2 mg/dL. Urinalysis showed a urinary pH of 9. Which of the following is the likely diagnosis? (NEET PG 2024)</span></p>",
      "unique_key": "Q1878888",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446548,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans</strong>. <strong>B) Type 1 RTA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient’s laboratory findings indicate metabolic acidosis with a blood pH of 7.28, low bicarbonate (HCO3 of 12 mEq/L), and normal anion gap, suggesting a non-anion gap metabolic acidosis (NAGMA). The hypokalemia (K 2.8 mEq/L) and a urinary pH of 9, which indicates alkaline urine, are key diagnostic clues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Type 1 Renal Tubular Acidosis (RTA)</strong>, also known as distal RTA, is characterized by the inability of the distal nephron to acidify the urine, resulting in a persistently high urinary pH (usually &gt;5.5). This condition often presents with hypokalemia due to impaired hydrogen ion excretion. The patient’s alkaline urine and hypokalemia strongly support the diagnosis of Type 1 RTA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Type 4 RTA:</strong> Type 4 RTA typically presents with hyperkalemia due to aldosterone deficiency or resistance, which is not seen here. The presence of hypokalemia rules out this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Type 2 RTA:</strong> Type 2 RTA, or proximal RTA, involves a defect in bicarbonate reabsorption. While it also presents with metabolic acidosis and hypokalemia, the urine can often be acidified after a bicarbonate load, resulting in a lower pH. The high urinary pH observed here is not consistent with Type 2 RTA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Respiratory acidosis:</strong> This condition would present with elevated pCO2 and acidemia due to impaired ventilation. The patient's normal anion gap and metabolic acidosis rule out respiratory acidosis as a diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Type 1 RTA (distal RTA) is identified by a combination of metabolic acidosis, hypokalemia, and an inability to acidify the urine, leading to an alkaline urinary pH, which is a distinct feature not seen in other RTAs.</span></p>",
      "correct_choice_id": 237034,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59430/Neet_Pg_Aug_2024_Medicine_Q_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59430/Neet_Pg_Aug_2024_Medicine_Q_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59431,
      "choices": [
        {
          "id": 237037,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron</span></p>"
        },
        {
          "id": 237038,
          "text": "<p><span style=\"font-size:12.0pt;\">Methanol</span></p>"
        },
        {
          "id": 237039,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethylene glycol</span></p>"
        },
        {
          "id": 237040,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old male presents with altered mental status, tachycardia, tachypnea, and hypertension after consuming an unknown substance. On evaluation, he has high anion gap metabolic acidosis and hypocalcemia. Which of the following is likely to be the reason for his presentation? (NEET PG 2024)</span></p>",
      "unique_key": "Q9901179",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446549,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ethylene glycol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ethylene glycol poisoning typically presents with high anion gap metabolic acidosis due to its toxic metabolites, glycolic acid and oxalic acid. The formation of oxalic acid can lead to hypocalcemia because it binds calcium, forming insoluble calcium oxalate crystals. These crystals can deposit in the kidneys, leading to acute kidney injury (AKI). The clinical presentation of altered mental status, tachycardia, tachypnea, hypertension, high anion gap metabolic acidosis, and hypocalcemia is highly suggestive of ethylene glycol poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Iron:</strong> Iron toxicity generally presents with gastrointestinal symptoms, metabolic acidosis, and shock but does not cause hypocalcemia. It also typically leads to elevated serum iron levels and liver dysfunction rather than the metabolic acidosis pattern seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Methanol:</strong> Methanol poisoning also causes high anion gap metabolic acidosis, but it is primarily associated with visual disturbances (such as blindness) due to its toxic metabolite, formic acid. It does not cause hypocalcemia and has different systemic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Digoxin:</strong> Digoxin toxicity typically presents with gastrointestinal symptoms, visual disturbances like xanthopsia (yellow vision), arrhythmias, and hyperkalemia rather than metabolic acidosis and hypocalcemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ethylene glycol poisoning presents with high anion gap metabolic acidosis, hypocalcemia, and potential acute kidney injury due to the formation of calcium oxalate crystals from its toxic metabolites.</span></p>",
      "correct_choice_id": 237039,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59431/Neet_Pg_Aug_2024_Medicine_Q_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59431/Neet_Pg_Aug_2024_Medicine_Q_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59432,
      "choices": [
        {
          "id": 237041,
          "text": "<p><span style=\"font-size:12.0pt;\">Knee jerk present</span></p>"
        },
        {
          "id": 237042,
          "text": "<p><span style=\"font-size:12.0pt;\">RR of 18/min</span></p>"
        },
        {
          "id": 237043,
          "text": "<p><span style=\"font-size:12.0pt;\">S. Mg level of 6 mEq/L</span></p>"
        },
        {
          "id": 237044,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine output of 15 mL/hour</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old woman with a history of eclampsia is being administered a maintenance dose of magnesium sulfate. When will you stop magnesium sulfate? (NEET PG 2024)</span></p>",
      "unique_key": "Q2794165",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446550,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Urine output of 15 mL/hour</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Magnesium sulfate is used in the management of eclampsia to prevent seizures. It is essential to monitor the patient for signs of magnesium toxicity, which can be life-threatening. The major parameters to monitor include deep tendon reflexes (e.g., knee jerk), respiratory rate, serum magnesium levels, and urine output.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A critical parameter for the continuation of magnesium sulfate therapy is adequate urine output. The minimum urine output required is 100 mL over 4 hours (or about 25 mL/hour). Urine output below this threshold suggests inadequate excretion of magnesium, increasing the risk of toxicity. Therefore, a urine output of 15 mL/hour indicates a need to stop magnesium sulfate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Knee jerk present:</strong> The presence of knee jerk reflexes indicates that the patient has not yet reached the initial signs of magnesium toxicity. Stopping magnesium sulfate is not indicated based on this finding alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. RR of 18/min:</strong> This is a normal respiratory rate, indicating that there is no respiratory depression. Stopping magnesium sulfate is not necessary in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. S. Mg level of 6 mEq/L:</strong> This serum magnesium level is within the therapeutic range for eclampsia management. Therefore, it does not necessitate stopping the medication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Magnesium sulfate should be discontinued if the urine output is less than 100 mL over 4 hours, indicating impaired magnesium excretion and a risk of toxicity.</span></p>",
      "correct_choice_id": 237044,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59432/Neet_Pg_Aug_2024_Medicine_Q_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "CriteriaBased",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59432/Neet_Pg_Aug_2024_Medicine_Q_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59433,
      "choices": [
        {
          "id": 237045,
          "text": "<p><span style=\"font-size:12.0pt;\">Mostly in children</span></p>"
        },
        {
          "id": 237046,
          "text": "<p><span style=\"font-size:12.0pt;\">Mostly malignant</span></p>"
        },
        {
          "id": 237047,
          "text": "<p><span style=\"font-size:12.0pt;\">Can be seen in MEN 2A</span></p>"
        },
        {
          "id": 237048,
          "text": "<p><span style=\"font-size:12.0pt;\">Mostly bilateral</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old male presented with headache, palpitations, and hypertension. On evaluation, his urinary VMA and catecholamines were elevated. Imaging revealed an adrenal mass, and the patient underwent surgery and resection. Histology of the mass was shown. Which of the following is true regarding the condition? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-25-125853.jpg\" alt=\"\" width=\"300\" height=\"252\"></span></p>",
      "unique_key": "Q3003259",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446551,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Can be seen in MEN 2A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient’s symptoms, elevated urinary vanillylmandelic acid (VMA) and catecholamines, and the presence of an adrenal mass indicate pheochromocytoma, a catecholamine-secreting tumor. Pheochromocytomas can present with classic symptoms of headache, palpitations, and hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Association with MEN 2A</strong>: Pheochromocytomas are often seen in multiple endocrine neoplasia type 2A (MEN2A) and type 2B (MEN2B) syndromes. These syndromes are genetic conditions characterized by medullary thyroid cancer, pheochromocytoma, and other endocrine abnormalities. MEN2A specifically involves pheochromocytoma, medullary thyroid carcinoma, and parathyroid hyperplasia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mostly in children</strong>: Pheochromocytomas are not mostly seen in children; they occur predominantly in adults. Only about 10% of cases are seen in children.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Mostly malignant</strong>: Most pheochromocytomas are benign. Only about 10-15% of these tumors are malignant, contrary to the statement that they are \"mostly malignant.\"</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mostly bilateral</strong>: Pheochromocytomas are usually unilateral, with only about 10-12% being bilateral. Bilateral cases are more commonly associated with genetic conditions like MEN syndromes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pheochromocytomas can be seen in MEN2A and MEN2B syndromes, which are genetic conditions associated with multiple endocrine tumors, including pheochromocytoma</span></p>",
      "correct_choice_id": 237047,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59433/Neet_Pg_Aug_2024_Medicine_Q_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59433/Neet_Pg_Aug_2024_Medicine_Q_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59434,
      "choices": [
        {
          "id": 237049,
          "text": "<p><span style=\"font-size:12.0pt;\">ACTH</span></p>"
        },
        {
          "id": 237050,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrocortisone and fludrocortisone</span></p>"
        },
        {
          "id": 237051,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexamethasone</span></p>"
        },
        {
          "id": 237052,
          "text": "<p><span style=\"font-size:12.0pt;\">NaCl infusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34-year-old patient presents with lethargy and tiredness. On examination, he has hyperpigmentation around the lips. His BP is 90/60 mm Hg and heart rate is 110/min. Labs revealed a Na⁺ of 125 mEq/L and a K⁺ of 5.5 mEq/L. What is the most appropriate treatment? (NEET PG 2024)</span></p>",
      "unique_key": "Q1193511",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446552,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>B) Hydrocortisone and fludrocortisone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient’s presentation suggests primary adrenal insufficiency, specifically Addison's disease, which is characterized by lethargy, hypotension, hyperpigmentation, hyponatremia, and hyperkalemia. Primary adrenal insufficiency involves a deficiency of both glucocorticoids (cortisol) and mineralocorticoids (aldosterone). Therefore, the appropriate management is to replace both with hydrocortisone (a glucocorticoid) and fludrocortisone (a mineralocorticoid) to correct the hormonal deficiencies and electrolyte imbalances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. ACTH:</strong> ACTH (adrenocorticotropic hormone) is not a treatment; it is used diagnostically to assess adrenal function. It is not appropriate as a therapeutic measure in adrenal insufficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Dexamethasone:</strong> In primary adrenal insufficiency, dexamethasone alone is inadequate because it does not address the mineralocorticoid deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. NaCl infusion:</strong> While saline infusion can help correct electrolyte disturbances temporarily, it does not address the underlying hormone deficiencies and is not sufficient as a standalone treatment for adrenal insufficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Primary adrenal insufficiency requires replacement therapy with both glucocorticoids and mineralocorticoids. Hydrocortisone and fludrocortisone are the mainstays of treatment.</span></p>",
      "correct_choice_id": 237050,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59434/Neet_Pg_Aug_2024_Medicine_Q_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59434/Neet_Pg_Aug_2024_Medicine_Q_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59435,
      "choices": [
        {
          "id": 237053,
          "text": "<p><span style=\"font-size:12.0pt;\">GHRH levels</span></p>"
        },
        {
          "id": 237054,
          "text": "<p><span style=\"font-size:12.0pt;\">Age-matched IGF-1 levels</span></p>"
        },
        {
          "id": 237055,
          "text": "<p><span style=\"font-size:12.0pt;\">Random GH levels</span></p>"
        },
        {
          "id": 237056,
          "text": "<p><span style=\"font-size:12.0pt;\">GH levels after 2 hours of administration of 75g glucose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old patient presents with large, sweaty hands, macroglossia, and prominent frontal bossing. The patient also reports increasing shoe size and difficulty wearing rings that previously fit. Considering the clinical features, which of the following tests is the most appropriate initial investigation? (NEET PG 2024)</span></p>",
      "unique_key": "Q8737356",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446553,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Age-matched IGF-1 levels</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical features described—large hands, macroglossia, prominent frontal bossing, and changes in shoe and ring sizes—are characteristic of acromegaly, a condition caused by excessive growth hormone (GH) secretion, usually due to a pituitary adenoma. The initial and most appropriate screening test for acromegaly is measuring age-matched IGF-1 (Insulin-like Growth Factor-1) levels. IGF-1 reflects average GH levels and is less variable than GH, making it a reliable marker for diagnosing acromegaly. The test must be age-matched because IGF-1 levels naturally decline with age, and using incorrect age ranges could lead to misinterpretation of results.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. GHRH levels:</strong> Measuring GHRH is rarely useful in the initial assessment and is reserved for cases where ectopic GHRH secretion is suspected. It is not a primary diagnostic tool for acromegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Random GH levels:</strong> Random measurement of GH is not reliable due to the pulsatile nature of GH secretion. Levels fluctuate throughout the day, making this test inappropriate for diagnosing acromegaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. GH levels after 2 hours of administration of 75g glucose:</strong> This is a confirmatory test, not an initial screening test. Normally, GH levels should be suppressed to undetectable levels (&lt;1 ng/mL) following glucose administration. Failure of suppression confirms acromegaly but is not used as the first line of investigation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The initial test of choice for acromegaly is measuring age-matched IGF-1 levels, which serves as a reliable screening method due to its consistent reflection of GH levels over time.</span></p>",
      "correct_choice_id": 237054,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59435/Neet_Pg_Aug_2024_Medicine_Q_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59435/Neet_Pg_Aug_2024_Medicine_Q_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59436,
      "choices": [
        {
          "id": 237057,
          "text": "<p><span style=\"font-size:12.0pt;\">Hodgkin's Lymphoma - ABVD regimen</span></p>"
        },
        {
          "id": 237058,
          "text": "<p><span style=\"font-size:12.0pt;\">NHL - Rituximab monotherapy</span></p>"
        },
        {
          "id": 237059,
          "text": "<p><span style=\"font-size:12.0pt;\">NHL - advanced stage - treated with radiotherapy</span></p>"
        },
        {
          "id": 237060,
          "text": "<p><span style=\"font-size:12.0pt;\">Sarcoidosis - Started on Prednisolone 40 mg/day</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman came with complaints of fever, night sweats, generalized itching, and unintentional weight loss of 10% in the last 3 months. On examination, she has enlarged cervical and axillary lymph nodes. The lymph node examination and biopsy showed the following picture. What would the likely diagnosis and treatment option be? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-25-125917.jpg\" alt=\"\" width=\"300\" height=\"225\"></span></p>",
      "unique_key": "Q1535849",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446554,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Hodgkin's Lymphoma - ABVD regimen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of fever, night sweats, unintentional weight loss (collectively known as B symptoms), along with generalized itching and lymphadenopathy, strongly suggests a diagnosis of Hodgkin's Lymphoma (HL). The biopsy finding of classic Reed-Sternberg cells, which are large abnormal lymphocytes often found in Hodgkin's Lymphoma, confirms this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hodgkin’s Lymphoma is treated primarily with the ABVD regimen, which includes the drugs Adriamycin (doxorubicin), Bleomycin, Vinblastine, and Dacarbazine. This regimen is the standard initial treatment for classical Hodgkin’s Lymphoma and may be supplemented with involved site radiotherapy (ISRT) in select cases. In cases of refractory or relapsed disease, Brentuximab Vedotin, an anti-CD30 monoclonal antibody-drug conjugate, may be added.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. NHL - Rituximab monotherapy:</strong> The question describes a case of Hodgkin’s lymphoma</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. NHL - advanced stage - treated with radiotherapy:</strong> The question describes a case of Hodgkin’s lymphoma</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sarcoidosis - Started on Prednisolone 40 mg/day:</strong> The question describes a case of Hodgkin’s lymphoma</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hodgkin’s Lymphoma is characterized by the presence of Reed-Sternberg cells on biopsy and is treated with the ABVD chemotherapy regimen, often combined with radiotherapy in specific cases.</span></p>",
      "correct_choice_id": 237057,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59436/Neet_Pg_Aug_2024_Medicine_Q_21.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59436/Neet_Pg_Aug_2024_Medicine_Q_21.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59437,
      "choices": [
        {
          "id": 237061,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic Hepatitis B with HBeAg negative</span></p>"
        },
        {
          "id": 237062,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic Hepatitis B with HBeAg positive</span></p>"
        },
        {
          "id": 237063,
          "text": "<p><span style=\"font-size:12.0pt;\">Resolved infection</span></p>"
        },
        {
          "id": 237064,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute Hepatitis B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man had an episode of jaundice due to HBV one year back. On follow-up now, he has normal levels of liver enzymes. His current profile is shown in the image. What is the diagnosis for his current condition? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-25-125934.jpg\" alt=\"\" width=\"700\" height=\"362\"></span></p>",
      "unique_key": "Q6472407",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446555,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>B) Chronic Hepatitis B with HBeAg positive</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The patient had jaundice due to Hepatitis B one year ago and now presents with persistent Hepatitis B surface antigen (HBsAg), which is visible in the profile as the orange line indicating ongoing infection. According to the definition, Chronic Hepatitis B is diagnosed when HBsAg persists for more than six months. In this case, the presence of HBeAg (Hepatitis B e-antigen) positivity indicates active viral replication and higher infectivity, confirming the diagnosis of chronic Hepatitis B with HBeAg positive status.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Chronic Hepatitis B with HBeAg negative:</strong> This condition involves the persistence of HBsAg but without the presence of HBeAg. The patient’s profile shows HBeAg positivity, ruling out this option.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Resolved infection:</strong> Resolved infection would be characterized by the disappearance of HBsAg and the presence of anti-HBs antibodies. The patient’s profile still shows HBsAg, indicating ongoing infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Acute Hepatitis B:</strong> Acute Hepatitis B would occur within the first six months of infection. Given that the infection has persisted for over a year, this is a chronic condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Chronic Hepatitis B is defined by the persistence of HBsAg for more than six months. The presence of HBeAg indicates active viral replication, characterizing the infection as HBeAg positive.</span></p>",
      "correct_choice_id": 237062,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59437/Neet_Pg_Aug_2024_Medicine_Q_22.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59437/Neet_Pg_Aug_2024_Medicine_Q_22.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59438,
      "choices": [
        {
          "id": 237065,
          "text": "<p><span style=\"font-size:12.0pt;\">Flow cytometry is the gold standard for diagnosis</span></p>"
        },
        {
          "id": 237066,
          "text": "<p><span style=\"font-size:12.0pt;\">It is an inherited disorder with chronic intravascular hemolysis and frequent exacerbations</span></p>"
        },
        {
          "id": 237067,
          "text": "<p><span style=\"font-size:12.0pt;\">Most common cause of death is heart failure and anemia</span></p>"
        },
        {
          "id": 237068,
          "text": "<p><span style=\"font-size:12.0pt;\">Sucrose lysis test is useful for confirming the diagnosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true regarding the diagnosis of Paroxysmal Nocturnal Hemoglobinuria (PNH)? (NEET PG 2024)</span></p>",
      "unique_key": "Q6139367",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446556,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Flow cytometry is the gold standard for diagnosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Flow cytometry is considered the gold standard for diagnosing PNH as it detects the deficiency of GPI-anchored proteins such as CD55 and CD59 on red blood cells, which are characteristic of this condition. This method is highly sensitive and specific, allowing for the detection of even small populations of PNH cells, making it the most accurate and preferred diagnostic tool.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is an inherited disorder with chronic intravascular hemolysis and frequent exacerbations:</strong> PNH is not an inherited disorder; it is an acquired disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Most common cause of death is heart failure and anemia:</strong> The most common cause of death in PNH is thromboembolism, not heart failure or anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sucrose lysis test is useful for confirming the diagnosis:</strong> The sucrose lysis test is outdated and is no longer considered reliable or standard in modern diagnostic practices for PNH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Flow cytometry is the gold standard for diagnosing PNH, focusing on detecting deficiencies of GPI-anchored proteins such as CD55 and CD59 on blood cells.</span></p>",
      "correct_choice_id": 237065,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59438/Neet_Pg_Aug_2024_Medicine_Q_23.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59438/Neet_Pg_Aug_2024_Medicine_Q_23.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59439,
      "choices": [
        {
          "id": 237069,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelets</span></p>"
        },
        {
          "id": 237070,
          "text": "<p><span style=\"font-size:12.0pt;\">Hematocrit</span></p>"
        },
        {
          "id": 237071,
          "text": "<p><span style=\"font-size:12.0pt;\">Total Leukocyte Count</span></p>"
        },
        {
          "id": 237072,
          "text": "<p><span style=\"font-size:12.0pt;\">Albumin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old male presented with fever and myalgia. On examination, he had a diffuse maculopapular rash. Labs revealed a Hb of 14 g/dL, Hematocrit of 55%, Total WBC count of 4000, and platelet count of 25,000. Which of the following is the best prognostic indicator? (NEET PG 2024)</span></p>",
      "unique_key": "Q6533285",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446557,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hematocrit</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation and laboratory findings suggest a diagnosis of dengue fever, a common viral infection characterized by fever, rash, myalgia, thrombocytopenia (low platelets), and elevated hematocrit due to plasma leakage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Hematocrit is the best prognostic indicator in dengue fever</strong> as it reflects the severity of plasma leakage, which can lead to hypovolemia, shock, and severe dengue. Monitoring hematocrit helps guide fluid management. A rising hematocrit indicates worsening plasma leakage, necessitating aggressive fluid replacement, while a falling hematocrit in a patient with shock suggests the need for blood transfusion. This makes hematocrit a critical marker in the management of dengue, as it directly influences therapeutic decisions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Platelets:</strong> While thrombocytopenia is a common finding in dengue and is monitored closely, platelet count alone does not directly guide fluid management or predict disease severity as effectively as hematocrit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Total Leukocyte Count:</strong> Leukopenia (low white blood cell count) is often seen in dengue but does not have significant prognostic value. It is not used to guide treatment decisions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Albumin:</strong> Low albumin levels can occur in severe dengue due to plasma leakage, but albumin is not the primary marker used for monitoring disease progression or guiding treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In dengue fever, hematocrit is the best prognostic indicator as it reflects the extent of plasma leakage and guides fluid management, which is crucial in preventing complications.</span></p>",
      "correct_choice_id": 237070,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59439/Neet_Pg_Aug_2024_Medicine_Q_24.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59439/Neet_Pg_Aug_2024_Medicine_Q_24.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59440,
      "choices": [
        {
          "id": 237073,
          "text": "<p><span style=\"font-size:12.0pt;\">AST</span></p>"
        },
        {
          "id": 237074,
          "text": "<p><span style=\"font-size:12.0pt;\">ALT</span></p>"
        },
        {
          "id": 237075,
          "text": "<p><span style=\"font-size:12.0pt;\">LDH</span></p>"
        },
        {
          "id": 237076,
          "text": "<p><span style=\"font-size:12.0pt;\">Tartrate resistant acid phosphatase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old female presented with a hip fracture. She has a past history of multiple fractures, and DEXA revealed a T-score of -2.7. Which of the following would be increased in her blood profile? (NEET PG 2024)</span></p>",
      "unique_key": "Q1657690",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446558,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Tartrate resistant acid phosphatase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's presentation with multiple fractures and a DEXA T-score of -2.7 indicates osteoporosis, a condition characterized by decreased bone density and increased risk of fractures. In osteoporosis, markers of bone resorption (osteoclastic activity) are often elevated due to increased bone turnover.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tartrate-resistant acid phosphatase (TRAP)</strong> is an enzyme that is specifically expressed by osteoclasts, the cells responsible for bone resorption. Elevated levels of TRAP indicate increased osteoclastic activity, which is a hallmark of bone loss seen in osteoporosis. Thus, TRAP serves as a marker of bone destruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other markers of bone resorption include urinary hydroxyproline, N-terminal telopeptide, and C-terminal telopeptide, but TRAP is particularly associated with osteoclastic activity and bone loss, making it the correct answer in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. AST (Aspartate Aminotransferase):</strong> AST is a liver enzyme and is not associated with bone metabolism or osteoclastic activity. It is typically elevated in liver diseases or muscle injury, not in conditions of increased bone resorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. ALT (Alanine Aminotransferase):</strong> ALT is another liver enzyme elevated in liver damage and is unrelated to bone metabolism or osteoporosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. LDH (Lactate Dehydrogenase):</strong> LDH is a non-specific enzyme that may be elevated in a variety of conditions, including tissue damage, hemolysis, and some cancers. It is not specific for bone metabolism or osteoporosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In osteoporosis, markers of increased bone resorption, such as Tartrate-resistant acid phosphatase (TRAP), are elevated due to increased osteoclastic activity. TRAP is specifically associated with bone loss and osteoclastic activity, distinguishing it from other enzymes that are unrelated to bone metabolism.</span></p>",
      "correct_choice_id": 237076,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59440/Neet_Pg_Aug_2024_Medicine_Q_25.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59440/Neet_Pg_Aug_2024_Medicine_Q_25.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59441,
      "choices": [
        {
          "id": 237077,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
        },
        {
          "id": 237078,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemolytic anemia</span></p>"
        },
        {
          "id": 237079,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoplastic anemia</span></p>"
        },
        {
          "id": 237080,
          "text": "<p><span style=\"font-size:12.0pt;\">Megaloblastic anemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old woman came with complaints of weakness and lethargy with a past history of heavy menstrual bleeding. Her peripheral blood smear showed microcytic RBCs. Her lab reports are as follows - Hb 7.9 mg/dl, MCV 65, MCH - low, TIBC - increased, Transferrin saturation - low. What is the likely diagnosis? (NEET PG 2024)</span></p>",
      "unique_key": "Q2898283",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446559,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Iron deficiency anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Iron deficiency anemia is characterized by microcytic, hypochromic red blood cells with low mean corpuscular volume (MCV) and low mean corpuscular hemoglobin (MCH). The patient’s lab findings, including a low hemoglobin level (7.9 g/dL), low MCV (65), and low transferrin saturation, are classic for iron deficiency anemia. Additionally, her past history of heavy menstrual bleeding suggests chronic blood loss, which is a common cause of iron deficiency anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The elevated total iron-binding capacity (TIBC) and low transferrin saturation further confirm iron deficiency, as the body increases TIBC in an attempt to bind and transport more iron due to the deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hemolytic anemia:</strong> Hemolytic anemia usually presents with normocytic red blood cells and a high reticulocyte count due to increased red blood cell turnover. It does not present with microcytic RBCs and does not have the iron deficiency profile seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hypoplastic anemia (Aplastic anemia):</strong> This type of anemia involves bone marrow failure, often presenting with pancytopenia (low counts of all blood cells) and normocytic or macrocytic RBCs, not microcytic RBCs. Iron parameters are generally normal or can be elevated due to reduced erythropoiesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Megaloblastic anemia:</strong> Megaloblastic anemia is characterized by macrocytic RBCs due to deficiencies in vitamin B12 or folate, not microcytic RBCs. It does not fit the patient's lab profile of low MCV and iron deficiency markers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Iron deficiency anemia presents with microcytic, hypochromic RBCs, low hemoglobin, low MCV, increased TIBC, and low transferrin saturation, often caused by chronic blood loss such as heavy menstrual bleeding.</span></p>",
      "correct_choice_id": 237077,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59441/Neet_Pg_Aug_2024_Medicine_Q_26.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59441/Neet_Pg_Aug_2024_Medicine_Q_26.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59442,
      "choices": [
        {
          "id": 237081,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoniazid</span></p>"
        },
        {
          "id": 237082,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin</span></p>"
        },
        {
          "id": 237083,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethambutol</span></p>"
        },
        {
          "id": 237084,
          "text": "<p><span style=\"font-size:12.0pt;\">Streptomycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with HIV who is currently on antiretroviral therapy consisting of zidovudine, lamivudine, and nevirapine is diagnosed with tuberculosis. Considering potential drug interactions, which of the following TB drugs should be changed in this patient? (NEET PG 2024)</span></p>",
      "unique_key": "Q8493807",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446560,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>B) Rifampicin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rifampicin is a potent enzyme inducer of the cytochrome P450 system, particularly CYP3A4, which is involved in the metabolism of many antiretroviral drugs, including nevirapine. This enzyme induction significantly lowers the plasma levels of nevirapine, potentially leading to antiretroviral therapy (ART) failure by reducing the drug's effectiveness against HIV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In practice, when treating a patient with both HIV and tuberculosis, rifampicin is usually continued due to its efficacy and availability. However, the antiretroviral therapy must be adjusted. Specifically, nevirapine should be replaced with an alternative ART drug that does not interact negatively with rifampicin, such as dolutegravir at a double dose or lopinavir/ritonavir at an adjusted dose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Isoniazid:</strong> Isoniazid does not have significant interactions with nevirapine and can be safely used in patients receiving ART.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ethambutol:</strong> Ethambutol does not interact significantly with antiretroviral drugs and is generally safe to use alongside ART.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Streptomycin:</strong> Streptomycin does not have major interactions with nevirapine or other antiretroviral drugs, making it safe to use in this combination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rifampicin interacts significantly with nevirapine due to its enzyme-inducing properties, lowering nevirapine levels and risking ART failure. Thus, when co-administered, antiretroviral therapy should be adjusted rather than discontinuing rifampicin.</span></p>",
      "correct_choice_id": 237082,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59442/Neet_Pg_Aug_2024_Medicine_Q_27.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59442/Neet_Pg_Aug_2024_Medicine_Q_27.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59443,
      "choices": [
        {
          "id": 237085,
          "text": "<p><span style=\"font-size:12.0pt;\">Monoclonal gammopathy of undetermined significance</span></p>"
        },
        {
          "id": 237086,
          "text": "<p><span style=\"font-size:12.0pt;\">Bone marrow - fibrinoid necrosis</span></p>"
        },
        {
          "id": 237087,
          "text": "<p><span style=\"font-size:12.0pt;\">Amyloidosis</span></p>"
        },
        {
          "id": 237088,
          "text": "<p><span style=\"font-size:12.0pt;\">Myxomatous degeneration of the bone marrow</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 53-year-old woman presents with complaints of fatigue, jaundice, edema, and hepatosplenomegaly. She had anemia and neutropenia. Her serum creatinine is 3.2 mg/dL, and her bone marrow examination showed 22% plasma cells, and her serum Ig levels were 3.0 g/dL. The bone marrow biopsy is shown below. What is the associated histology? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-25-125953.jpg\" alt=\"\" width=\"400\" height=\"158\"></span></p>",
      "unique_key": "Q5361771",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446561,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Amyloidosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation and findings in this patient strongly suggest a diagnosis of multiple myeloma with associated AL (amyloid light-chain) amyloidosis.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Multiple Myeloma Features</strong>: The patient has several features indicative of multiple myeloma, including anemia, renal impairment (high serum creatinine), increased plasma cells in the bone marrow (22%), and elevated immunoglobulin levels (&gt;3 g/dL), all of which are consistent with myeloma-defining events.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Amyloidosis Association</strong>: Amyloidosis is a common complication of multiple myeloma, particularly AL amyloidosis, where light chains deposit in tissues, leading to organ dysfunction. The presence of edema (often due to nephrotic syndrome or heart failure from amyloid cardiomyopathy) and hepatosplenomegaly (from amyloid infiltration) supports the diagnosis of amyloidosis.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Monoclonal gammopathy of undetermined significance (MGUS)</strong>: MGUS does not meet the criteria for multiple myeloma as it lacks myeloma-defining events like significant organ damage (CRAB features - hyperCalcemia, Renal failure, Anemia, Bone lesions).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Bone marrow - fibrinoid necrosis</strong>: This is not related to the clinical presentation or typical of multiple myeloma with amyloidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Myxomatous degeneration of the bone marrow</strong>: This is not associated with the clinical findings or typical complications of multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Multiple myeloma can be complicated by AL amyloidosis, which leads to symptoms such as edema, hepatosplenomegaly, and organ dysfunction due to amyloid deposits in various tissues.</span></p>",
      "correct_choice_id": 237087,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59443/Neet_Pg_Aug_2024_Medicine_Q_28.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59443/Neet_Pg_Aug_2024_Medicine_Q_28.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59444,
      "choices": [
        {
          "id": 237089,
          "text": "<p><span style=\"font-size:12.0pt;\">Amlodipine</span></p>"
        },
        {
          "id": 237090,
          "text": "<p><span style=\"font-size:12.0pt;\">Clonidine</span></p>"
        },
        {
          "id": 237091,
          "text": "<p><span style=\"font-size:12.0pt;\">Lisinopril</span></p>"
        },
        {
          "id": 237092,
          "text": "<p><span style=\"font-size:12.0pt;\">Telmisartan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A person was taking an antihypertensive drug prescribed for his hypertension. He was regular in his consumption despite having some constipation, dry mouth, and dizziness. Recently, he went on a trip away from the country and failed to carry his medications with him, and was not taking them since then. Currently, he presented to the OPD with a hypertensive emergency. What is the likely antihypertensive drug? (NEET PG 2024)</span></p>",
      "unique_key": "Q3622597",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446562,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>B) Clonidine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clonidine is a centrally acting alpha-2 agonist used to manage hypertension. It is known for causing side effects such as dry mouth, dizziness, and constipation, which match the symptoms described in the question. Clonidine is particularly notorious for causing rebound hypertension if suddenly discontinued, which can lead to a hypertensive emergency, as seen in this patient who stopped taking his medication during a trip. The abrupt cessation of clonidine leads to a surge in sympathetic activity, resulting in severe hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Amlodipine:</strong> Amlodipine is a calcium channel blocker that is commonly used to treat hypertension. It is well-tolerated and does not cause rebound hypertension upon sudden discontinuation, making it an unlikely cause of the hypertensive emergency in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lisinopril:</strong> Lisinopril is an ACE inhibitor used for hypertension. While it can cause a mild increase in blood pressure upon discontinuation, it does not lead to the severe rebound hypertension seen with clonidine. Moreover, its side effects do not typically include dry mouth, constipation, and dizziness as prominently as clonidine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Telmisartan:</strong> Telmisartan is an angiotensin receptor blocker (ARB) used in the treatment of hypertension. It does not cause significant withdrawal effects leading to a hypertensive emergency and does not match the side effect profile described in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clonidine is associated with rebound hypertension if suddenly stopped, which can lead to a hypertensive emergency. It is crucial for patients on clonidine to taper the medication rather than discontinue it abruptly.</span></p>",
      "correct_choice_id": 237090,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59444/Neet_Pg_Aug_2024_Medicine_Q_29.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59444/Neet_Pg_Aug_2024_Medicine_Q_29.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59445,
      "choices": [
        {
          "id": 237093,
          "text": "<p><span style=\"font-size:12.0pt;\">Astemizole</span></p>"
        },
        {
          "id": 237094,
          "text": "<p><span style=\"font-size:12.0pt;\">Cetirizine</span></p>"
        },
        {
          "id": 237095,
          "text": "<p><span style=\"font-size:12.0pt;\">Loratadine</span></p>"
        },
        {
          "id": 237096,
          "text": "<p><span style=\"font-size:12.0pt;\">Promethazine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs, when given with erythromycin, can cause QT prolongation and Torsades de pointes? (NEET PG 2024)</span></p>",
      "unique_key": "Q6797487",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446563,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Astemizole</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Astemizole is an antihistamine known to cause QT prolongation and an increased risk of Torsades de pointes, especially when combined with other medications that affect cardiac conduction, such as erythromycin. This dangerous interaction occurs because both drugs can interfere with cardiac potassium channels, prolonging the QT interval and predisposing the patient to potentially fatal arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Astemizole and terfenadine are notable among antihistamines for their high risk of causing Torsades de pointes, which has led to the withdrawal of terfenadine from the market. Astemizole, though less commonly used, still poses a significant risk when combined with drugs like erythromycin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cetirizine:</strong> Cetirizine is a second-generation antihistamine that does not significantly affect the QT interval and is not associated with Torsades de pointes when combined with erythromycin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Loratadine:</strong> Loratadine is another second-generation antihistamine with a good safety profile concerning cardiac conduction and QT interval prolongation, making it a safer choice in patients requiring antihistamine treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Promethazine:</strong> Although promethazine is a first-generation antihistamine, it does not carry the same risk of QT prolongation and Torsades de pointes as astemizole when used with erythromycin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Astemizole, when combined with erythromycin, can cause QT prolongation and Torsades de pointes due to its significant effect on cardiac potassium channels, posing a high risk of life-threatening arrhythmias.</span></p>",
      "correct_choice_id": 237093,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59445/Neet_Pg_Aug_2024_Medicine_Q_30.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59445/Neet_Pg_Aug_2024_Medicine_Q_30.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59446,
      "choices": [
        {
          "id": 237097,
          "text": "<p><span style=\"font-size:12.0pt;\">Lorazepam</span></p>"
        },
        {
          "id": 237098,
          "text": "<p><span style=\"font-size:12.0pt;\">Fomepizole</span></p>"
        },
        {
          "id": 237099,
          "text": "<p><span style=\"font-size:12.0pt;\">Disulfiram</span></p>"
        },
        {
          "id": 237100,
          "text": "<p><span style=\"font-size:12.0pt;\">Buspirone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male with a history of chronic alcohol use is admitted to the hospital. He presents with anxiety, tremors, and agitation after his last drink 24 hours ago. Which of the following medications is most appropriate for the control of alcohol withdrawal symptoms? (NEET PG 2024)</span></p>",
      "unique_key": "Q7918553",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446564,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Lorazepam</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with mild alcohol withdrawal symptoms, which commonly include anxiety, tremors, and agitation within 6-24 hours after the last drink. The gold standard treatment for alcohol withdrawal is benzodiazepines, which help manage the symptoms by enhancing the effect of the neurotransmitter GABA, thereby calming the nervous system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lorazepam is a short-acting benzodiazepine preferred in alcohol withdrawal, especially in patients with liver impairment due to its relatively safer hepatic metabolism compared to long-acting benzodiazepines. It helps reduce withdrawal symptoms and prevent progression to severe complications like delirium tremens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fomepizole:</strong> This medication is an alcohol dehydrogenase inhibitor used in the management of methanol or ethylene glycol poisoning. It is not used for treating alcohol withdrawal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Disulfiram:</strong> Disulfiram is used for long-term maintenance in alcohol dependence by discouraging alcohol intake through aversive effects. It does not play a role in managing acute withdrawal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Buspirone:</strong> Buspirone is an anxiolytic medication primarily used for generalized anxiety disorders. It is not effective in managing the acute symptoms of alcohol withdrawal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Benzodiazepines, such as lorazepam, are the first-line treatment for managing alcohol withdrawal symptoms, especially in patients with liver concerns.</span></p>",
      "correct_choice_id": 237097,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59446/Neet_Pg_Aug_2024_Medicine_Q_31.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59446/Neet_Pg_Aug_2024_Medicine_Q_31.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59447,
      "choices": [
        {
          "id": 237101,
          "text": "<p><span style=\"font-size:12.0pt;\">Atropine decreases the adverse effect of diphenoxylate</span></p>"
        },
        {
          "id": 237102,
          "text": "<p><span style=\"font-size:12.0pt;\">To prevent abuse of diphenoxylate</span></p>"
        },
        {
          "id": 237103,
          "text": "<p><span style=\"font-size:12.0pt;\">To enhance the antidiarrheal effect</span></p>"
        },
        {
          "id": 237104,
          "text": "<p><span style=\"font-size:12.0pt;\">Atropine produces direct spasmolytic action</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the rationale for the use of atropine in combination with diphenoxylate? (NEET PG 2024)</span></p>",
      "unique_key": "Q8626212",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446565,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) To prevent abuse of diphenoxylate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diphenoxylate is an opioid medication used to treat diarrhea. However, it also has the potential for abuse due to its opioid-like effects. Atropine, an anticholinergic drug, is added to diphenoxylate to discourage abuse. If someone tries to take a higher dose of diphenoxylate to get high, they will also ingest a higher dose of atropine, which will lead to unpleasant side effects like dry mouth, blurred vision, and dizziness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Atropine decreases the adverse effect of diphenoxylate</strong>: While atropine may counteract some of the cholinergic side effects of diphenoxylate (like excessive sweating or salivation), its primary purpose in this combination is not to reduce adverse effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. To enhance the antidiarrheal effect</strong>: Both diphenoxylate and atropine can slow down gut motility, but the main reason for combining them is not to enhance the antidiarrheal effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Atropine produces direct spasmolytic action</strong>: Atropine does have some antispasmodic effects, but its primary role in this combination is to deter abuse.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Atropine is combined with diphenoxylate to discourage abuse of this opioid anti-diarrheal medication.</span></p>",
      "correct_choice_id": 237102,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59447/Neet_Pg_Aug_2024_Medicine_Q_32.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59447/Neet_Pg_Aug_2024_Medicine_Q_32.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47637,
      "choices": [
        {
          "id": 190159,
          "text": "<p><span style=\"font-size:12.0pt;\">Furosemide</span></p>"
        },
        {
          "id": 190160,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiloride</span></p>"
        },
        {
          "id": 190161,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetazolamide</span></p>"
        },
        {
          "id": 190162,
          "text": "<p><span style=\"font-size:12.0pt;\">Indapamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient having hypertension, is on thiazides and is complaining of fatigue and hypokalemia. Which of the following drug can prevent potassium loss?</span></p>",
      "unique_key": "Q5306021",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446566,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Amiloride</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thiazide diuretics, such as hydrochlorothiazide, indapamide, chlorthalidone, and metolazone, are known for causing potassium wasting, which can result in hypokalemia and associated symptoms like fatigue. To counteract this effect, potassium-sparing diuretics can be used.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amiloride is an epithelial sodium channel (ENaC) inhibitor, which is a type of potassium-sparing diuretic. It helps prevent potassium loss by inhibiting sodium reabsorption in the distal tubules of the kidneys, thereby reducing potassium excretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Furosemide</strong>: This is a loop diuretic, which also causes potassium wasting and is not suitable for preventing potassium loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Acetazolamide</strong>: This is a carbonic anhydrase inhibitor diuretic, which is not typically used for potassium conservation and can also cause electrolyte imbalances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Indapamide</strong>: This is another thiazide-like diuretic, which also causes potassium wasting and does not prevent potassium loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amiloride is a potassium-sparing diuretic that can be used to prevent potassium loss in patients on thiazide diuretics.</span></p>",
      "correct_choice_id": 190160,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55394,
      "choices": [
        {
          "id": 221037,
          "text": "<p><span style=\"font-size:12pt;\">Filtration fraction</span></p>"
        },
        {
          "id": 221038,
          "text": "<p><span style=\"font-size:12pt;\">Tubular secretion</span></p>"
        },
        {
          "id": 221039,
          "text": "<p><span style=\"font-size:12pt;\">Tubular reabsorption</span></p>"
        },
        {
          "id": 221040,
          "text": "<p><span style=\"font-size:12pt;\">Clearance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What renal function does the formula UV/P represent? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q5881707",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446567,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Clearance</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Renal clearance is a measure of the volume of plasma from which a substance is completely removed by the kidneys per unit time. It provides important information about the efficiency with which the kidneys can filter out a substance from the bloodstream and excrete it in the urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The formula is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Clearance(C) = UV /P ​</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Where:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">C is the clearance of the substance.</span></li><li><span style=\"font-size:12pt;\">U is the concentration of the substance in the urine.</span></li><li><span style=\"font-size:12pt;\">V is the urine flow rate (volume of urine produced per unit time).</span></li><li><span style=\"font-size:12pt;\">P is the concentration of the substance in the plasma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Filtration fraction:</strong> This is the ratio of the glomerular filtration rate (GFR) to the renal plasma flow (RPF).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Tubular secretion:</strong> This refers to the active process by which substances are transported from the blood into the renal tubule. While clearance can involve secretion, the formula UV/P specifically calculates overall clearance, not just secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Tubular reabsorption:</strong> This refers to the process by which substances are reabsorbed from the renal tubule back into the blood. The UV/P formula does not directly represent reabsorption but overall clearance, which can include filtration and reabsorption processes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The formula UV/P is used to calculate the renal clearance of a substance, reflecting the volume of plasma from which the kidneys can completely remove that substance per unit time.</span></p>",
      "correct_choice_id": 221040,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55398,
      "choices": [
        {
          "id": 221053,
          "text": "<p><span style=\"font-size:12pt;\">Low volume blood patch</span></p>"
        },
        {
          "id": 221054,
          "text": "<p><span style=\"font-size:12pt;\">Increase caffeine</span></p>"
        },
        {
          "id": 221055,
          "text": "<p><span style=\"font-size:12pt;\">Fluid restriction</span></p>"
        },
        {
          "id": 221056,
          "text": "<p><span style=\"font-size:12pt;\">Stool softeners</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 24-year-old female who had a lumbar puncture continues to have a headache. Which of the following is not recommended? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q7683813",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446568,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Fluid restriction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient is experiencing a post-dural puncture headache (PDPH), which can occur after a lumbar puncture due to the leakage of cerebrospinal fluid (CSF). This type of headache is typically treated with a variety of supportive measures to alleviate symptoms and promote healing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Fluid restriction is not recommended for patients with PDPH. &nbsp;In fact, liberal fluid intake is advised to help replace the lost CSF and maintain adequate hydration, which can aid in reducing the headache.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Low volume blood patch:</strong> An epidural blood patch is an effective treatment for PDPH, particularly in refractory cases. It involves injecting a small amount of the patient's own blood into the epidural space to seal the CSF leak.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Increase caffeine:</strong> Caffeine is known to help reduce the severity of PDPH due to its vasoconstrictive properties, which can help alleviate the headache.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Stool softeners:</strong> Stool softeners are recommended to prevent straining during bowel movements, which can exacerbate the headache. Constipation is common in postoperative patients due to the use of anesthetics and other medications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the management of post-dural puncture headache, fluid restriction is not recommended. Instead, measures such as epidural blood patches, increased caffeine intake, and stool softeners are utilized to manage symptoms and promote recovery.</span></p>",
      "correct_choice_id": 221055,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47638,
      "choices": [
        {
          "id": 190163,
          "text": "<p><span style=\"font-size:12.0pt;\">1 aerobic and 1 anaerobic</span></p>"
        },
        {
          "id": 190164,
          "text": "<p><span style=\"font-size:12.0pt;\">3 samples - 1 aerobic, 2 anaerobic</span></p>"
        },
        {
          "id": 190165,
          "text": "<p><span style=\"font-size:12.0pt;\">3 samples - 2 aerobic and 1 anaerobic</span></p>"
        },
        {
          "id": 190166,
          "text": "<p><span style=\"font-size:12.0pt;\">3 aerobic and 3 anaerobic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">How will you collect samples for blood culture in a patient with suspected Infective Endocarditis?</span></p>",
      "unique_key": "Q6968148",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446569,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 3 aerobic and 3 anaerobic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Infective endocarditis is diagnosed using <strong>Duke's criteria</strong>, which includes major and minor criteria. One of the major criteria involves positive blood cultures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For accurate diagnosis, it is essential to collect multiple blood cultures to identify the causative organism reliably.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A blood <strong>culture set</strong> includes both aerobic and anaerobic samples.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to Duke's criteria:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>A minimum of two cultures should be drawn at least 12 hours apart.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Ideally, three or more cultures should be collected.</strong></span></li><li><span style=\"font-size:12.0pt;\">When collecting three or more cultures, each culture set includes both aerobic and anaerobic samples.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, for three culture sets, you would collect three aerobic and three anaerobic samples.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The rules for collection are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">If two culture sets are collected, both should be drawn at least 12 hours apart and both should be positive.</span></li><li><span style=\"font-size:12.0pt;\">If three or more culture sets are collected, all three should be positive for the same organism.</span></li><li><span style=\"font-size:12.0pt;\">If more than three culture sets are collected, the majority should be positive for the same organism.</span></li><li><span style=\"font-size:12.0pt;\"><strong>The gap between the first and the last culture should be at least one hour.</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For suspected infective endocarditis, the recommended blood culture collection includes three aerobic and three anaerobic samples to ensure accurate diagnosis and identification of the causative organism</span></p>",
      "correct_choice_id": 190166,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55399,
      "choices": [
        {
          "id": 221057,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myasthenia Gravis</span></span></p>"
        },
        {
          "id": 221058,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lambert Eaton Syndrome</span></span></p>"
        },
        {
          "id": 221059,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myotonic dystrophy</span></span></p>"
        },
        {
          "id": 221060,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Guillain Barre syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">18-year-old girl presents with bilateral ptosis and difficulty in chewing and combing. Her problems tend to worsen with activity. What is the diagnosis?<strong> </strong>(FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q6694593",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446570,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Myasthenia Gravis</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myasthenia Gravis is an autoimmune neuromuscular disorder characterized by weakness and fatigue of the skeletal muscles. The weakness typically worsens with activity and improves with rest, which is a hallmark of the disease. The symptoms are caused by antibodies that block or destroy nicotinic acetylcholine receptors at the neuromuscular junction, leading to decreased transmission of nerve impulses to the muscles.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In this case, the presence of bilateral ptosis (drooping of the eyelids) and difficulty in activities such as chewing and combing, which worsen with activity, are classic signs of Myasthenia Gravis. These symptoms reflect the muscle fatigue and weakness that are characteristic of the condition.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Lambert Eaton Syndrome</strong>: This condition also involves muscle weakness, but it typically improves with repeated activity. It is often associated with small cell lung cancer and involves autoantibodies against presynaptic calcium channels, leading to reduced acetylcholine release.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Myotonic dystrophy: </strong>This genetic disorder involves progressive muscle wasting and weakness but does not typically present with ptosis and the fluctuating weakness seen in Myasthenia Gravis. It is characterized by myotonia (difficulty relaxing muscles) rather than fatigue with activity.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Guillain Barre syndrome: </strong>&nbsp;An acute autoimmune disorder that affects the peripheral nervous system, leading to rapid onset of muscle weakness and paralysis. It does not present with ptosis and is associated with ascending muscle weakness rather than fatigue that worsens with activity.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myasthenia Gravis is characterized by muscle weakness that worsens with activity and improves with rest, with ptosis and difficulty in tasks requiring sustained muscle effort being common symptoms.</span></span></p>",
      "correct_choice_id": 221057,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47639,
      "choices": [
        {
          "id": 190167,
          "text": "<p><span style=\"font-size:12.0pt;\">Microangiopathic anemia</span></p>"
        },
        {
          "id": 190168,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickling crisis</span></p>"
        },
        {
          "id": 190169,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia</span></p>"
        },
        {
          "id": 190170,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune hemolytic anemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with hemolytic anemia presents with index finger pain and chest pain. The patient has Hb of 5.6 gm/dl and an increase in unconjugated bilirubin in serum. What is the most likely diagnosis? (</span>FMGE Jan 2024)</p>",
      "unique_key": "Q9148844",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446571,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Sickling crisis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with hemolytic anemia, evidenced by a low hemoglobin level of 5.6 gm/dl and an increase in unconjugated bilirubin, indicating hemolysis. The specific symptoms of index finger pain and chest pain are highly suggestive of <strong>a sickling crisis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In sickle cell disease, patients may experience episodes of severe pain, known as sickle cell crises or vaso-occlusive crises, due to the blockage of blood flow by sickled red blood cells. The index finger pain (dactylitis) and chest pain (acute chest syndrome) are classic manifestations of such crises. Acute chest syndrome is a severe complication of sickle cell disease that presents with chest pain, fever, and pulmonary infiltrates.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Microangiopathic anemia</strong>: This condition involves the destruction of red blood cells in small blood vessels but does not typically present with the specific symptoms of dactylitis and acute chest syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thalassemia</strong>: While thalassemia also causes hemolytic anemia, it does not usually present with dactylitis or acute chest syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Autoimmune hemolytic anemia</strong>: This condition involves the immune system attacking red blood cells but lacks the specific signs of sickle cell crisis, such as dactylitis and acute chest syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with hemolytic anemia presenting with severe pain in the fingers (dactylitis) and chest pain (acute chest syndrome), sickle cell crisis is the most likely diagnosis.</span></p>",
      "correct_choice_id": 190168,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55400,
      "choices": [
        {
          "id": 221061,
          "text": "<p><span style=\"font-size:12pt;\">EMG</span></p>"
        },
        {
          "id": 221062,
          "text": "<p><span style=\"font-size:12pt;\">CT scan chest</span></p>"
        },
        {
          "id": 221063,
          "text": "<p><span style=\"font-size:12pt;\">Acetylcholinesterase test</span></p>"
        },
        {
          "id": 221064,
          "text": "<p><span style=\"font-size:12pt;\">Nerve conduction velocity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 30-year-old woman complains of ptosis and diplopia that worsens with activity and improves with rest. What is the most sensitive investigation? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q7589689",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446572,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) EMG (Electromyography)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The symptoms of ptosis and diplopia that worsen with activity and improve with rest are characteristic of myasthenia gravis, a neuromuscular disorder caused by autoimmune destruction of acetylcholine receptors at the neuromuscular junction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most sensitive investigation for myasthenia gravis is <strong>single fiber</strong> <strong>electromyography </strong>(SF-EMG), which detects abnormalities in the neuromuscular transmission by measuring the electrical activity of muscle fibers. Even if single fiber EMG is not specifically mentioned, standard EMG is still highly sensitive and appropriate for diagnosing myasthenia gravis. Another practical test used is repetitive nerve stimulation (RNS), which shows a decremental response in myasthenia gravis patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. CT scan chest:</strong> This is usually performed in confirmed myasthenia gravis patients to rule out thymoma, but it is not the most sensitive test for diagnosing the condition itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Acetylcholinesterase test:</strong> Also known as the edrophonium test or Tensilon test, this can be used to diagnose myasthenia gravis by temporarily improving muscle strength. However, it has variable sensitivity and specificity and is less sensitive than EMG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Nerve conduction velocity:</strong> This test is more relevant in the diagnosis of neuropathies, particularly demyelinating neuropathies, where conduction velocities are decreased. It is not the most sensitive test for myasthenia gravis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most sensitive investigation for diagnosing myasthenia gravis is electromyography (EMG), particularly single fiber EMG, which detects abnormalities in neuromuscular transmission.</span></p>",
      "correct_choice_id": 221061,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47640,
      "choices": [
        {
          "id": 190171,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumothorax</span></p>"
        },
        {
          "id": 190172,
          "text": "<p><span style=\"font-size:12.0pt;\">Consolidation</span></p>"
        },
        {
          "id": 190173,
          "text": "<p><span style=\"font-size:12.0pt;\">Collapse</span></p>"
        },
        {
          "id": 190174,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural effusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient came to emergency with severe breathlessness. CXR is taken and shown below. What is the diagnosis? (</span>FMGE Jan 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-112146.png\" alt=\"\" width=\"300\" height=\"257\"></span></p>",
      "unique_key": "Q7658351",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446573,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Pleural effusion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The chest X-ray (CXR) of the patient shows a whiteout on one side with a significant tracheal shift to the opposite side. These findings are indicative of a massive pleural effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Pleural effusion</strong>: This condition results in the accumulation of fluid in the pleural space, leading to lung compression and a shift of the mediastinum, including the trachea, away from the affected side. The presence of a large whiteout on the X-ray, along with the tracheal deviation to the opposite side, strongly suggests pleural effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pneumothorax</strong>: This condition would typically present with a hyperlucent (dark) area on the X-ray without lung markings, rather than a whiteout. It also generally causes a tracheal shift towards the opposite side, but the appearance on the X-ray would be different.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Consolidation</strong>: This condition involves filling of the alveoli with fluid or other material, leading to a whiteout appearance on the X-ray. However, it does not usually cause a significant tracheal shift.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Collapse</strong>: This condition, also known as atelectasis, would cause a shift of the trachea towards the affected side. It can present with a whiteout on the X-ray, but the tracheal deviation would be opposite to that seen in pleural effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A massive pleural effusion is characterized by a whiteout on the chest X-ray with a significant tracheal shift to the opposite side.</span></p>",
      "correct_choice_id": 190174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55401,
      "choices": [
        {
          "id": 221065,
          "text": "<p><span style=\"font-size:12pt;\">CN III</span></p>"
        },
        {
          "id": 221066,
          "text": "<p><span style=\"font-size:12pt;\">CN IV</span></p>"
        },
        {
          "id": 221067,
          "text": "<p><span style=\"font-size:12pt;\">CN VI</span></p>"
        },
        {
          "id": 221068,
          "text": "<p><span style=\"font-size:12pt;\">CN VII</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Innervation of lateral rectus is by which nerve? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q5673004",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446574,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) CN VI</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The lateral rectus muscle, which is responsible for moving the eye laterally (abduction), is innervated by the sixth cranial nerve, also known as the abducens nerve. This nerve specifically controls the lateral rectus muscle, allowing for the lateral movement of the eyeball.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. CN III (Oculomotor nerve):</strong> The oculomotor nerve innervates most of the other extraocular muscles, including the medial rectus, superior rectus, inferior rectus, and inferior oblique muscles. It is not responsible for innervating the lateral rectus muscle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. CN IV (Trochlear nerve):</strong> The trochlear nerve innervates only the superior oblique muscle, which is involved in downward and outward movement of the eye. It does not innervate the lateral rectus muscle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. CN VII (Facial nerve):</strong> The facial nerve is primarily responsible for the muscles of facial expression. It does not innervate any of the extraocular muscles, including the lateral rectus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The lateral rectus muscle is innervated by the sixth cranial nerve (CN VI), also known as the abducens nerve.</span></p>",
      "correct_choice_id": 221067,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47641,
      "choices": [
        {
          "id": 190175,
          "text": "<p><span style=\"font-size:12.0pt;\">Melanocyte Stimulating Hormone (MSH)</span></p>"
        },
        {
          "id": 190176,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemosiderin</span></p>"
        },
        {
          "id": 190177,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuropeptide Y</span></p>"
        },
        {
          "id": 190178,
          "text": "<p><span style=\"font-size:12.0pt;\">Melanin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A chronic smoker presented with weight gain and hyperpigmentation of palms and soles. He was subsequently diagnosed to have lung cancer. Which of the following is responsible for hyperpigmentation? (</span>FMGE Jan 2024)</p>",
      "unique_key": "Q1253225",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446575,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Melanocyte Stimulating Hormone (MSH)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient, a chronic smoker, presented with weight gain and hyperpigmentation of the palms and soles and was diagnosed with lung cancer. This clinical scenario suggests the presence of an ectopic ACTH-producing tumor, most commonly associated with small cell lung cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In such cases, the excessive ACTH produced by the tumor can lead to Cushing's syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Additionally, ACTH has an intrinsic MSH (Melanocyte Stimulating Hormone) activity due to the shared precursor molecule, proopiomelanocortin (POMC). The MSH part within ACTH stimulates melanocytes, leading to increased melanin production and resulting in hyperpigmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hemosiderin</strong>: Hemosiderin is an iron-storage complex. It does not play a role in causing hyperpigmentation in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Neuropeptide Y</strong>: Neuropeptide Y is involved in various physiological processes, including regulation of appetite and stress responses, but not in causing hyperpigmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Melanin</strong>: While melanin is the pigment responsible for skin color, its production is stimulated by MSH. Thus, MSH is the direct cause of increased melanin and subsequent hyperpigmentation in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of ectopic ACTH production, such as with small cell lung cancer, hyperpigmentation occurs due to the MSH activity of ACTH, which stimulates melanocytes to produce melanin.</span></p>",
      "correct_choice_id": 190175,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55402,
      "choices": [
        {
          "id": 221069,
          "text": "<p><span style=\"font-size:12pt;\">Neurofibromatosis</span></p>"
        },
        {
          "id": 221070,
          "text": "<p><span style=\"font-size:12pt;\">Tuberous sclerosis</span></p>"
        },
        {
          "id": 221071,
          "text": "<p><span style=\"font-size:12pt;\">Sturge-Weber syndrome</span></p>"
        },
        {
          "id": 221072,
          "text": "<p><span style=\"font-size:12pt;\">Von Hippel Lindau syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient presented with 2 Lisch nodules in the iris. What is the possible diagnosis? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q2993866",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446576,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Neurofibromatosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Lisch nodules are pigmented, benign hamartomas found in the iris of the eye. They are highly specific to Neurofibromatosis type 1 (NF1), also known as von Recklinghausen disease. NF1 is a genetic disorder characterized by the development of multiple benign tumors called neurofibromas, café-au-lait spots, and other neurological and ocular manifestations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Key diagnostic feature:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Lisch nodules:</strong> These are melanocytic hamartomas and are considered a hallmark of NF1. Their presence, particularly when there are two or more, is diagnostic of NF1.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Tuberous sclerosis:</strong> This genetic disorder is characterized by the growth of benign tumors in multiple organs, including the brain, skin, kidneys, and heart. It is associated with other ocular findings such as retinal hamartomas, but not with Lisch nodules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Sturge-Weber syndrome:</strong> This congenital disorder is associated with a port-wine stain birthmark, neurological abnormalities, and ocular issues like glaucoma, but not with Lisch nodules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Von Hippel Lindau syndrome:</strong> This is a genetic disorder that leads to the formation of tumors and cysts in different parts of the body, particularly the kidneys, pancreas, and central nervous system. It is not associated with Lisch nodules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The presence of Lisch nodules in the iris is highly specific for Neurofibromatosis type 1 (NF1), making it a key diagnostic feature for this condition</span></p>",
      "correct_choice_id": 221069,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47642,
      "choices": [
        {
          "id": 190179,
          "text": "<p><span style=\"font-size:12.0pt;\">QT prolongation</span></p>"
        },
        {
          "id": 190180,
          "text": "<p><span style=\"font-size:12.0pt;\">PR prolongation</span></p>"
        },
        {
          "id": 190181,
          "text": "<p><span style=\"font-size:12.0pt;\">ST elevation</span></p>"
        },
        {
          "id": 190182,
          "text": "<p><span style=\"font-size:12.0pt;\">Wide QRS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the likely ECG change associated with Bedaquiline?</span></p>",
      "unique_key": "Q7842035",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446577,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) QT prolongation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bedaquiline is a modern anti-tubercular drug used primarily for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis. One of the significant side effects of bedaquiline is QT prolongation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">QT prolongation is a measure of delayed ventricular repolarization, which can be seen on an ECG as an extended QT interval. This side effect is critical as it can predispose patients to potentially fatal arrhythmias, such as Torsades de Pointes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. PR prolongation</strong>: This represents delayed atrioventricular conduction and is not a known side effect of bedaquiline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. ST elevation</strong>: This is typically associated with myocardial infarction and is not a side effect of bedaquiline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Wide QRS</strong>: This indicates delayed intraventricular conduction and is not associated with bedaquiline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bedaquiline, an important drug for treating MDR and XDR tuberculosis, is known for causing QT prolongation on ECG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note -</strong> <strong>The \"Q\" in bedaquiline can be a mnemonic to remember this important side effect.</strong></span></p>",
      "correct_choice_id": 190179,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55403,
      "choices": [
        {
          "id": 221073,
          "text": "<p><span style=\"font-size:12pt;\">Acute Bacterial Meningitis</span></p>"
        },
        {
          "id": 221074,
          "text": "<p><span style=\"font-size:12pt;\">Viral Meningitis</span></p>"
        },
        {
          "id": 221075,
          "text": "<p><span style=\"font-size:12pt;\">TB Meningitis</span></p>"
        },
        {
          "id": 221076,
          "text": "<p><span style=\"font-size:12pt;\">Fungal Meningitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 34-year-old patient presented with fever, headache, vomiting, and neck stiffness. Lumbar puncture was performed, and the reports are as follows: (FMGE JULY 2024)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Opening pressure – elevated</span></li><li><span style=\"font-size:12pt;\">Appearance – cloudy</span></li><li><span style=\"font-size:12pt;\">Cell count – 80 (70% PMNs)</span></li><li><span style=\"font-size:12pt;\">Sugar – 35 mg/dL</span></li><li><span style=\"font-size:12pt;\">Protein – 200 mg/dL</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">What is the likely diagnosis?</span></p>",
      "unique_key": "Q7937137",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446578,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Acute Bacterial Meningitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient presents with symptoms suggestive of meningitis: fever, headache, vomiting, and neck stiffness. The cerebrospinal fluid (CSF) analysis from the lumbar puncture provides several key clues:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Elevated opening pressure, which is common in bacterial meningitis.</span></li><li><span style=\"font-size:12pt;\">Cloudy appearance of the CSF, indicating a high number of cells or increased protein.</span></li><li><span style=\"font-size:12pt;\">Cell count of 80 with 70% polymorphonuclear leukocytes (PMNs), which is highly indicative of bacterial infection as it typically shows a neutrophilic predominance.</span></li><li><span style=\"font-size:12pt;\">Low glucose level (35 mg/dL) and elevated protein level (200 mg/dL), which are consistent with bacterial meningitis due to the consumption of glucose by bacteria and increased protein from the inflammatory process.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Viral Meningitis: </strong>Viral meningitis usually presents with a lymphocytic predominance in the CSF, normal or slightly elevated protein, and normal glucose levels. This does not match the neutrophil predominance and low glucose levels seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C</strong>. <strong>TB Meningitis: </strong>TB meningitis often shows a lymphocytic predominance in the CSF, significantly elevated protein levels, and moderately low glucose levels. While the glucose and protein levels could fit, the neutrophil predominance makes TB meningitis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Fungal Meningitis: </strong>Fungal meningitis typically presents with a mixed or lymphocytic predominance in the CSF, elevated protein, and low glucose. Neutrophilic predominance is not characteristic of fungal meningitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Acute bacterial meningitis is characterized by elevated opening pressure, cloudy CSF, a high cell count with neutrophilic predominance, low glucose, and elevated protein levels in the CSF.</span></p>",
      "correct_choice_id": 221073,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47643,
      "choices": [
        {
          "id": 190183,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypokalemia</span></p>"
        },
        {
          "id": 190184,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperkalemia</span></p>"
        },
        {
          "id": 190185,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypocalcemia</span></p>"
        },
        {
          "id": 190186,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypophosphatemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following electrolyte abnormalities are seen in Refeeding Syndrome except: (</span>FMGE Jan 2024)</p>",
      "unique_key": "Q6705368",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446579,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hyperkalemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Refeeding syndrome occurs when nutrients are reintroduced to a severely malnourished patient, leading to metabolic and electrolyte disturbances. The reintroduction of carbohydrates causes an insulin surge, which drives electrolytes into cells, resulting in the following abnormalities:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Hypokalemia</strong>: Potassium is driven into cells, lowering serum levels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hypophosphatemia</strong>: Phosphate is used up in the production of ATP, lowering serum levels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hypocalcemia</strong>: Increased cellular uptake of calcium can lower serum levels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These hypoelectrolyte states are critical to monitor as they can lead to severe complications such as cardiac arrhythmias, muscle weakness, and respiratory failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option &nbsp;A.&nbsp; Hypokalemia</strong>: This is not seen in refeeding syndrome. Instead, refeeding syndrome typically results in hypokalemia due to the intracellular shift of potassium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hypocalcemia</strong>: Seen due to the cellular uptake of calcium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hypophosphatemia</strong>: A hallmark of refeeding syndrome, driven by increased cellular utilization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Refeeding syndrome is characterized by multiple hypoelectrolyte abnormalities, including hypokalemia, hypophosphatemia, and hypocalcemia, but not hyperkalemia.</span></p>",
      "correct_choice_id": 190184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55404,
      "choices": [
        {
          "id": 221077,
          "text": "<p><span style=\"font-size:12pt;\">Ibuprofen</span></p>"
        },
        {
          "id": 221078,
          "text": "<p><span style=\"font-size:12pt;\">Sumatriptan</span></p>"
        },
        {
          "id": 221079,
          "text": "<p><span style=\"font-size:12pt;\">Propranolol</span></p>"
        },
        {
          "id": 221080,
          "text": "<p><span style=\"font-size:12pt;\">Verapamil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 58-year-old hypertensive patient with a history of myocardial infarction (MI) presents with an acute attack of migraine. Which of the following medications should not be given?<strong> </strong>(FMGE JULY 2024)</span></p>",
      "unique_key": "Q1086541",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446580,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Sumatriptan</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sumatriptan is a medication used to treat acute migraine attacks and works as a selective serotonin receptor agonist (<strong>5-HT1B/1D receptor agonist</strong>). However, it is contraindicated in patients with a history of coronary artery disease (CAD) or other significant cardiovascular diseases, including previous myocardial infarction (MI). This is because sumatriptan can cause <strong>vasoconstriction</strong>, which can exacerbate these conditions, leading to serious cardiovascular events.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A</strong>. <strong>Ibuprofen:&nbsp;</strong> A nonsteroidal anti-inflammatory drug (NSAID) that can be used to treat migraine pain. It does not have the same cardiovascular risks as triptans and can be safely used in patients with a history of MI, although caution is advised in hypertensive patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> <strong>Propranolol:&nbsp;</strong> A beta-blocker often used for migraine prophylaxis. It is actually beneficial for patients with a history of MI as it reduces the risk of further cardiac events by lowering heart rate and blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Verapamil: </strong>A calcium channel blocker that is sometimes used for migraine prevention. It is generally safe for use in patients with a history of MI and can help manage hypertension as well.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sumatriptan, a vasoconstrictor, should not be given to patients with a history of coronary artery disease or myocardial infarction due to the risk of triggering serious cardiovascular events.</span></p>",
      "correct_choice_id": 221078,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47644,
      "choices": [
        {
          "id": 190187,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HLA B51</span></span></span></span></p>"
        },
        {
          "id": 190188,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HLA B27</span></span></span></span></p>"
        },
        {
          "id": 190189,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HLA DR4</span></span></span></span></p>"
        },
        {
          "id": 190190,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HLA B8</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reiter&#39;s syndrome is associated with: (</span></span>FMGE Jan 2024)</p>",
      "unique_key": "Q4787256",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446581,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) HLA B27</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reiter&#39;s syndrome, also known as reactive arthritis, is strongly associated with the HLA-B27 antigen. This association is part of a broader category of diseases called seronegative spondyloarthropathies. The key conditions linked with HLA-B27 include:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ankylosing Spondylitis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This condition has the highest association with HLA-B27.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Psoriatic Arthritis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A form of arthritis that affects some people with psoriasis.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reactive Arthritis (Reiter&#39;s Syndrome)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Characterized by a triad of arthritis, urethritis, and conjunctivitis.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enteropathic Arthritis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Associated with inflammatory bowel diseases like Crohn&#39;s disease and ulcerative colitis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. HLA B51</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It is linked with Beh&ccedil;et&#39;s disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. HLA DR4</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Associated with rheumatoid arthritis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. HLA B8</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Associated with diseases such as myasthenia gravis and celiac disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives:</span></span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reiter&#39;s syndrome is part of the seronegative spondyloarthropathies and is strongly associated with the HLA-B27 antigen.</span></span></span></span></p>",
      "correct_choice_id": 190188,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55405,
      "choices": [
        {
          "id": 221081,
          "text": "<p><span style=\"font-size:12pt;\">Delirium tremens</span></p>"
        },
        {
          "id": 221082,
          "text": "<p><span style=\"font-size:12pt;\">Wernicke Encephalopathy</span></p>"
        },
        {
          "id": 221083,
          "text": "<p><span style=\"font-size:12pt;\">Korsakoff Psychosis</span></p>"
        },
        {
          "id": 221084,
          "text": "<p><span style=\"font-size:12pt;\">Withdrawal seizures</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A chronic alcoholic came with complaints of agitation, disorientation, hallucination, fever, hypertension, and diaphoresis after stopping alcohol intake for 48 hours. Which of the following is the diagnosis? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q3076640",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446616,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Delirium tremens</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Delirium tremens (DT) is a severe form of alcohol withdrawal that usually occurs 48 to 96 hours after cessation of heavy, prolonged alcohol use. It is characterized by agitation, disorientation, hallucinations, fever, hypertension, and diaphoresis, which indicate autonomic instability. Delirium tremens is a medical emergency and can be life-threatening without appropriate treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The <strong>first-line treatment</strong> for delirium tremens is <strong>benzodiazepines, particularly diazepam.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In patients with liver cirrhosis, shorter-acting benzodiazepines like oxazepam, temazepam, or lorazepam are preferred due to their safer profile in hepatic impairment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Wernicke Encephalopathy:</strong> This condition is characterized by confusion, ataxia, and ophthalmoplegia due to thiamine deficiency but does not typically present with autonomic instability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Korsakoff Psychosis:</strong> This is a chronic memory disorder caused by severe thiamine deficiency, often seen in chronic alcoholism, but it does not present with the acute autonomic instability seen in delirium tremens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Withdrawal seizures:</strong> These can occur within 6 to 48 hours after alcohol cessation but are not associated with the severe autonomic instability and other symptoms of delirium tremens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Delirium tremens is a <strong>severe, life-threatening</strong> form of alcohol withdrawal that occurs 48 to 96 hours after cessation of alcohol intake, characterized by autonomic instability, agitation, disorientation, and hallucinations. The first-line treatment is benzodiazepines, particularly diazepam.</span></p>",
      "correct_choice_id": 221081,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11627,
      "choices": [
        {
          "id": 46474,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MRI showing &lt; 1/3rd of MCA territorial infarct</span></span></span></p>"
        },
        {
          "id": 46475,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood pressure of &gt; 185/110 mmHg</span></span></span></p>"
        },
        {
          "id": 46476,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ischemia &lt; 2 hours</span></span></span></p>"
        },
        {
          "id": 46477,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Onset of symptoms &lt; 4 hours</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombolysis can be considered in all of these conditions, except:</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q2949716",
      "question_audio": null,
      "question_video": null,
      "map_id": 35446617,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Blood pressure of &gt; 185/110 mmHg</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood pressure of &gt; 185/110 mmHg: This is a contraindication for thrombolysis. Elevated blood pressure increases the risk of hemorrhagic complications during thrombolysis. Therefore, blood pressure must be controlled to below 185/110 mmHg before initiating thrombolytic therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombolysis is a treatment used to dissolve blood clots in certain types of stroke patients. It is most effective when administered within a specific time window from the onset of symptoms and under certain conditions to ensure patient safety and efficacy of the treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. MRI showing &lt; 1/3rd of MCA territorial infarct:</span></strong><span style=\"font-size:12.0pt\"> This indicates that the infarct size is within a range that is generally considered safe for thrombolysis. More extensive infarcts (&gt; 1/3rd of the middle cerebral artery territory) are a contraindication due to the higher risk of hemorrhagic transformation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><span style=\"font-size:12.0pt\"> <strong>C. Ischemia &lt; 2 hours and D. Onset of symptoms &lt; 4 hours</strong>: Both of these options fall within the critical time window for thrombolysis, which is generally considered up to 4.5 hours from symptom onset. Treatment within this time frame can significantly improve outcomes in stroke patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombolysis is contraindicated in patients with blood pressure higher than 185/110 mmHg at the time of treatment.</span></span></span></p>",
      "correct_choice_id": 46475,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}